Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-1|1|420|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study 
|2-2-1-2|1|447|Neoplasia malignant|Upper digestive tract,MA: 0000346 - salivary gland| benign,MPATH: 549 - carcinoma|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-3|1|474|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-4|1|577|Other deterministic changes|Whole body|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-5|1|620|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-6|1|647|Other deterministic changes|Whole body|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-7|1|651|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-8|1|662|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland| benign,MPATH: 218 - neoplasm|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-9|1|664|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-10|1|672|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-11|1|676|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-12|1|687|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-13|1|708|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-14|1|729|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-15|1|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-16|1|748|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-17|1|749|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-18|1|751|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-19|1|756|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-20|1|769|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-21|1|778|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-22|1|786|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-23|1|809|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-24|1|821|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-25|1|846|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-26|1|848|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-27|1|850|Other deterministic changes|Lower respiratory system|n/a|
2-2-1|Rn-WL120-WLM 40,23-1,81/77|1| 77|Rn-222 gas|40|working level months|Inhalation| Inhaled over 1 m at 120 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-1-28|1|853|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-1|2|366|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-2|2|419|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-3|2|420|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-4|2|421|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-5|2|422|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-6|2|446|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-7|2|446|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-8|2|446|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-9|2|446|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-10|2|446|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-11|2|446|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-12|2|446|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-13|2|446|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-14|2|457|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-15|2|458|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-16|2|459|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-17|2|460|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-18|2|461|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-19|2|476|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-20|2|476|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-21|2|476|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-22|2|476|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-23|2|476|Other deterministic changes|Lower respiratory system|n/a|
2-2-2|Rn-WL15-WLM 50,12/88|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1 m at 15 WL|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-2-24|2|476|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-1|3|63|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-2|3|274|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-3|3|300|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-4|3|315|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-5|3|329|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-6|3|330|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-7|3|341|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-8|3|345|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-9|3|345|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-10|3|345|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-11|3|346|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-12|3|440|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-13|3|440|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-14|3|443|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-15|3|453|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-16|3|454|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-17|3|470|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-18|3|470|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-19|3|475|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-20|3|475|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-21|3|476|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-22|3|477|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-23|3|486|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-24|3|495|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-25|3|513|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-26|3|513|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-27|3|516|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-28|3|544|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-29|3|544|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-30|3|544|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-31|3|548|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-32|3|555|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-33|3|567|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-34|3|574|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-35|3|576|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-36|3|576|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-37|3|582|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-38|3|597|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-39|3|611|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-40|3|616|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-41|3|617|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-42|3|618|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-43|3|622|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-44|3|623|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-45|3|626|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-46|3|629|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-47|3|629|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-48|3|630|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-49|3|630|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-50|3|630|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-51|3|632|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-52|3|632|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-53|3|640|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-54|3|643|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-55|3|643|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-56|3|648|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-57|3|652|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-58|3|652|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-59|3|652|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-60|3|652|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-61|3|657|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-62|3|658|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-63|3|661|Neoplasia benign|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-64|3|661|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-65|3|665|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-66|3|667|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-67|3|668|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-68|3|668|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-69|3|668|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-70|3|671|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-71|3|675|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-72|3|678|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-73|3|680|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-74|3|682|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-75|3|685|Hyperplastic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-76|3|685|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-77|3|685|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-78|3|686|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-79|3|688|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-80|3|695|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-81|3|696|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-82|3|699|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-83|3|699|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-84|3|699|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-85|3|700|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-86|3|700|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-87|3|701|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-88|3|702|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-89|3|704|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-90|3|704|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-91|3|706|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-92|3|706|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-93|3|708|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-94|3|708|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-95|3|708|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-96|3|708|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-97|3|709|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-98|3|710|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-99|3|713|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-100|3|713|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-101|3|714|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-102|3|718|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-103|3|718|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-104|3|718|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-105|3|722|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-106|3|723|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-107|3|723|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-108|3|728|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-109|3|729|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-110|3|731|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-111|3|734|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-112|3|734|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-113|3|734|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-114|3|734|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-115|3|735|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-116|3|736|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-117|3|736|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-118|3|741|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-119|3|741|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-120|3|742|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-121|3|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-122|3|746|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-123|3|746|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-124|3|748|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-125|3|748|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-126|3|748|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-127|3|749|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-128|3|750|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-129|3|750|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-130|3|750|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-131|3|751|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-132|3|751|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-133|3|751|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-134|3|752|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-135|3|753|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-136|3|753|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-137|3|755|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-138|3|755|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-139|3|755|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-140|3|756|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-141|3|757|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-142|3|758|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-143|3|760|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-144|3|762|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-145|3|762|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-146|3|762|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-147|3|763|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-148|3|764|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-149|3|764|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-150|3|764|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-151|3|765|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-152|3|765|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-153|3|765|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-154|3|769|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-155|3|769|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-156|3|770|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-157|3|770|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-158|3|770|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-159|3|770|Hyperplastic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-160|3|771|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-161|3|772|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-162|3|774|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-163|3|776|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-164|3|776|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-165|3|776|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-166|3|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-167|3|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-168|3|781|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-169|3|781|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-170|3|783|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-171|3|783|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-172|3|784|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-173|3|784|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-174|3|785|Neoplasia malignant|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-175|3|785|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-176|3|786|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-177|3|786|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-178|3|787|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-179|3|790|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-180|3|790|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-181|3|791|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-182|3|791|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-183|3|792|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-184|3|792|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-185|3|794|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-186|3|795|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-187|3|797|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-188|3|797|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-189|3|797|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-190|3|800|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-191|3|800|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-192|3|800|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-193|3|801|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-194|3|804|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-195|3|804|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-196|3|806|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-197|3|808|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-198|3|808|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-199|3|809|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-200|3|811|Hyperplastic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-201|3|811|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-202|3|811|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-203|3|811|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-204|3|811|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-205|3|811|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-206|3|812|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-207|3|812|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-208|3|812|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-209|3|814|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-210|3|815|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-211|3|815|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-212|3|818|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-213|3|818|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-214|3|818|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-215|3|818|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-216|3|819|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-217|3|820|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-218|3|820|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-219|3|821|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-220|3|821|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-221|3|821|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-222|3|822|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-223|3|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-224|3|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-225|3|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-226|3|828|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-227|3|829|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-228|3|830|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-229|3|833|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-230|3|834|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-231|3|836|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-232|3|837|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-233|3|839|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-234|3|839|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-235|3|839|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-236|3|839|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-237|3|843|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-238|3|843|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-239|3|846|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-240|3|847|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-241|3|847|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-242|3|850|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-243|3|853|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-244|3|853|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-245|3|853|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-246|3|853|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-247|3|853|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-248|3|856|Neoplasia malignant|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-249|3|858|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-250|3|860|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-251|3|867|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-252|3|867|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-253|3|871|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-254|3|872|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-255|3|872|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-256|3|872|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-257|3|875|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-258|3|876|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-259|3|876|Neoplasia malignant|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-260|3|877|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-261|3|878|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-262|3|878|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-263|3|879|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-264|3|883|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-265|3|888|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-266|3|888|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-267|3|889|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-268|3|892|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-269|3|902|Other deterministic changes|Whole body|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-270|3|902|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-271|3|904|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-272|3|905|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-273|3|906|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-274|3|907|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-275|3|910|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-276|3|913|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-277|3|914|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-278|3|917|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-279|3|917|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-280|3|917|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-281|3|917|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-282|3|917|Hyperplastic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-283|3|917|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-284|3|917|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-285|3|917|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-286|3|917|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-287|3|918|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-288|3|918|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-289|3|918|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-290|3|918|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-291|3|918|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-292|3|918|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-293|3|918|Other deterministic changes|Lower respiratory system|n/a|
2-2-3|Rn-WL114-WLM 50,15-1-6-3/75|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 1.5 m at 114 WL|294 (294 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-3-294|3|918|Other deterministic changes|Lower respiratory system|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-1|4|284|Other deterministic changes|Whole body|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-2|4|327|Other deterministic changes|Whole body|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-3|4|328|Other deterministic changes|Whole body|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-4|4|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-5|4|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-6|4|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-7|4|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-8|4|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-9|4|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-10|4|759|Other deterministic changes|Lower respiratory system|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-11|4|759|Other deterministic changes|Lower respiratory system|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-12|4|759|Other deterministic changes|Lower respiratory system|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-13|4|759|Other deterministic changes|Lower respiratory system|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-14|4|759|Other deterministic changes|Lower respiratory system|n/a|
2-2-4|Rn-WL800-WL 87,21-8 3/76|1| 77|Rn-222 gas|87|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-4-15|4|759|Other deterministic changes|Lower respiratory system|n/a|
2-2-5|Rn-WL60-WLM 145,4-1 1/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 60 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-5-1|5|692|Other deterministic changes|Whole body|n/a|
2-2-5|Rn-WL60-WLM 145,4-1 1/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 60 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-5-2|5|702|Other deterministic changes|Whole body|n/a|
2-2-5|Rn-WL60-WLM 145,4-1 1/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 60 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-5-3|5|727|Other deterministic changes|Whole body|n/a|
2-2-5|Rn-WL60-WLM 145,4-1 1/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 60 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-5-4|5|763|Other deterministic changes|Whole body|n/a|
2-2-5|Rn-WL60-WLM 145,4-1 1/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 60 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-5-5|5|782|Other deterministic changes|Whole body|n/a|
2-2-5|Rn-WL60-WLM 145,4-1 1/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 60 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-5-6|5|834|Other deterministic changes|Whole body|n/a|
2-2-5|Rn-WL60-WLM 145,4-1 1/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 60 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-5-7|5|834|Other deterministic changes|Whole body|n/a|
2-2-5|Rn-WL60-WLM 145,4-1 1/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 60 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-5-8|5|834|Other deterministic changes|Whole body|n/a|
2-2-5|Rn-WL60-WLM 145,4-1 1/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 60 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-5-9|5|834|Other deterministic changes|Whole body|n/a|
2-2-5|Rn-WL60-WLM 145,4-1 1/72|1| 91|Rn-222 gas|145|working level months|Inhalation| Inhaled over 2 m at 60 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-5-10|5|834|Other deterministic changes|Whole body|n/a|
2-2-6|Rn-WL600-WLM 160,5-3 4-1 1/72|1| 91|Rn-222 gas|160|working level months|Inhalation| Inhaled over 2 m at 600 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-6-1|6|502|Other deterministic changes|Whole body|n/a|
2-2-6|Rn-WL600-WLM 160,5-3 4-1 1/72|1| 91|Rn-222 gas|160|working level months|Inhalation| Inhaled over 2 m at 600 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-6-2|6|515|Other deterministic changes|Whole body|n/a|
2-2-6|Rn-WL600-WLM 160,5-3 4-1 1/72|1| 91|Rn-222 gas|160|working level months|Inhalation| Inhaled over 2 m at 600 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-6-3|6|762|Other deterministic changes|Lower respiratory system|n/a|
2-2-6|Rn-WL600-WLM 160,5-3 4-1 1/72|1| 91|Rn-222 gas|160|working level months|Inhalation| Inhaled over 2 m at 600 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-6-4|6|769|Other deterministic changes|Whole body|n/a|
2-2-6|Rn-WL600-WLM 160,5-3 4-1 1/72|1| 91|Rn-222 gas|160|working level months|Inhalation| Inhaled over 2 m at 600 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-6-5|6|810|Other deterministic changes|Whole body|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-1|7|53|Neoplasia malignant|Reproductive system,MA: 0000404 - prostate gland|,MPATH: 268 - adenocarcinoma|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-2|7|634|Other deterministic changes|Whole body|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-3|7|646|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-4|7|652|Other deterministic changes|Whole body|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-5|7|652|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-6|7|659|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-7|7|659|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-8|7|665|Neoplasia benign|Lower respiratory system|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-9|7|668|Other deterministic changes|Lower respiratory system|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-10|7|677|Other deterministic changes|Lower respiratory system|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-11|7|679|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-12|7|692|Hyperplastic changes|Lower respiratory system|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-13|7|721|Other deterministic changes|Lower respiratory system|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-14|7|725|Neoplasia benign|Lower respiratory system|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-15|7|729|Other deterministic changes|Lower respiratory system|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-16|7|730|Other deterministic changes|Lower respiratory system|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-17|7|743|Other deterministic changes|Lower respiratory system|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-18|7|769|Hyperplastic changes|Lower respiratory system|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-19|7|769|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-20|7|777|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-21|7|778|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-22|7|797|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-23|7|828|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-24|7|833|Neoplasia benign|Lower respiratory system|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-25|7|836|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-26|7|857|Other deterministic changes|Lower respiratory system|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-27|7|860|Other deterministic changes|Lower respiratory system|n/a|
2-2-7|Rn-WL800-WLM 200,24-1,8 1/77|1| 77|Rn-222 gas|200|working level months|Inhalation| Inhaled over 0.5 m at 800 WL|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-7-28|7|891|Other deterministic changes|Lower respiratory system|n/a|
2-2-8|Rn-WL3000-WLM 225,S54 G21 10/83|Sequence:1, Age:77,Type:Rn-222 gas,Quantity:225,Unit:working level months,Application:Inhalation, Remarks:Inhaled over 0.1 m at 3000 WL|43 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|No information on individuals available for this study
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-1|9|272|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-2|9|272|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-3|9|272|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-4|9|272|Hyperplastic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-5|9|272|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-6|9|272|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-7|9|272|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-8|9|272|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-9|9|272|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-10|9|272|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-11|9|274|Hyperplastic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-12|9|336|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-13|9|362|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-14|9|362|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-15|9|362|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-16|9|362|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-17|9|362|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-18|9|362|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-19|9|362|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-20|9|362|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-21|9|362|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-22|9|362|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-23|9|392|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-24|9|392|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-25|9|392|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-26|9|392|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-27|9|392|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-28|9|392|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-29|9|392|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-30|9|392|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-31|9|392|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-32|9|392|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-33|9|400|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-34|9|467|Hyperplastic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-35|9|472|Hyperplastic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-36|9|472|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-37|9|472|Hyperplastic changes|Cardiovascular system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-38|9|472|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-39|9|472|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-40|9|472|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-41|9|472|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-42|9|472|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-43|9|472|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-44|9|472|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-45|9|515|Other deterministic changes|Whole body|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-46|9|542|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-47|9|542|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-48|9|542|Hyperplastic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-49|9|542|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-50|9|542|Hyperplastic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-51|9|542|Hyperplastic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-52|9|542|Hyperplastic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-53|9|542|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-54|9|542|Hyperplastic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-55|9|542|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-56|9|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-57|9|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-58|9|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-59|9|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-60|9|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-61|9|602|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-62|9|632|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-63|9|632|Neoplasia benign|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-64|9|632|Neoplasia benign|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-65|9|632|Neoplasia benign|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-66|9|632|Neoplasia benign|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-67|9|632|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-68|9|632|Other deterministic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-69|9|632|Neoplasia benign|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-70|9|632|Hyperplastic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-71|9|632|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-72|9|723|Hyperplastic changes|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-73|9|744|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-74|9|758|Other deterministic changes|Whole body|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-75|9|789|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-76|9|821|Neoplasia benign|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-77|9|825|Other deterministic changes|Whole body|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-78|9|825|Other deterministic changes|Whole body|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-79|9|827|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-80|9|827|Neoplasia benign|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-81|9|834|Other deterministic changes|Whole body|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-82|9|834|Other deterministic changes|Whole body|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-83|9|834|Neoplasia malignant|Lower respiratory system|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-84|9|834|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-85|9|834|Other deterministic changes|Whole body|n/a|
2-2-9|Rn-WL60-WLM 290,4- 2-9 5-3b 1/72|1| 91|Rn-222 gas|290|working level months|Inhalation| Inhaled over 2 m at 60 WL|86 (86 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|65 Serial sacrifice + 21 spont.death|2-2-9-86|9|834|Other deterministic changes|Whole body|n/a|
2-2-10|Rn-1500-WLM 500,43-141 10/80|1| 77|Rn-222 gas|500|working level months|Inhalation| Inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-10-1|10|538|Other deterministic changes|Lower respiratory system|n/a|
2-2-10|Rn-1500-WLM 500,43-141 10/80|1| 77|Rn-222 gas|500|working level months|Inhalation| Inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-10-2|10|650|Other deterministic changes|Lower respiratory system|n/a|
2-2-10|Rn-1500-WLM 500,43-141 10/80|1| 77|Rn-222 gas|500|working level months|Inhalation| Inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-10-3|10|686|Other deterministic changes|Lower respiratory system|n/a|
2-2-10|Rn-1500-WLM 500,43-141 10/80|1| 77|Rn-222 gas|500|working level months|Inhalation| Inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-10-4|10|778|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-10|Rn-1500-WLM 500,43-141 10/80|1| 77|Rn-222 gas|500|working level months|Inhalation| Inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-10-5|10|846|Hyperplastic changes|Lower respiratory system|n/a|
2-2-10|Rn-1500-WLM 500,43-141 10/80|1| 77|Rn-222 gas|500|working level months|Inhalation| Inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-10-6|10|868|Other deterministic changes|Lower respiratory system|n/a|
2-2-10|Rn-1500-WLM 500,43-141 10/80|1| 77|Rn-222 gas|500|working level months|Inhalation| Inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-10-7|10|876|Hyperplastic changes|Lower respiratory system|n/a|
2-2-10|Rn-1500-WLM 500,43-141 10/80|1| 77|Rn-222 gas|500|working level months|Inhalation| Inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-10-8|10|876|Hyperplastic changes|Lower respiratory system|n/a|
2-2-10|Rn-1500-WLM 500,43-141 10/80|1| 77|Rn-222 gas|500|working level months|Inhalation| Inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-10-9|10|876|Hyperplastic changes|Lower respiratory system|n/a|
2-2-10|Rn-1500-WLM 500,43-141 10/80|1| 77|Rn-222 gas|500|working level months|Inhalation| Inhaled over 0.75 m at 1500 WL|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study|2-2-10-10|10|876|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-1|11|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-2|11|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-3|11|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-4|11|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-5|11|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-6|11|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-7|11|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-8|11|392|Hyperplastic changes|Lower respiratory system|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-9|11|392|Hyperplastic changes|Lower respiratory system|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-10|11|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-11|11|422|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-12|11|520|Other deterministic changes|Whole body|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-13|11|608|Other deterministic changes|Lower respiratory system|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-14|11|665|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-15|11|729|Hyperplastic changes|Lower respiratory system|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-16|11|729|Other deterministic changes|Lower respiratory system|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-17|11|746|Other deterministic changes|Whole body|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-18|11|761|Other deterministic changes|Lower respiratory system|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-19|11|767|Other deterministic changes|Whole body|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-20|11|784|Hyperplastic changes|Lower respiratory system|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-21|11|792|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-22|11|824|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-23|11|824|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-24|11|834|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-25|11|855|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-26|11|876|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-27|11|876|Hyperplastic changes|Lower respiratory system|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-28|11|890|Hyperplastic changes|Lower respiratory system|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-29|11|890|Neoplasia malignant|Lower respiratory system|n/a|
2-2-11|Rn-2500-WLM 800,R1 3-1 6-1 10/72|1| 91|Rn-222 gas|800|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice + 20 spont.death|2-2-11-30|11|890|Neoplasia malignant|Lower respiratory system|n/a|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-1|12|290|Other deterministic changes|Lower respiratory system|n/a|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-2|12|390|Other deterministic changes|Lower respiratory system|n/a|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-3|12|492|Other deterministic changes|Lower respiratory system|n/a|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-4|12|505|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-5|12|505|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-6|12|532|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-7|12|532|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-8|12|547|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-9|12|560|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-10|12|570|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-11|12|583|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-12|12|584|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-13|12|619|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-14|12|636|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-15|12|639|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-12|Rn-WL1000-WLM 1000,26-5 4/77|1| 77|Rn-222 gas|1000|working level months|Inhalation| Inhaled over 1.5 m at 1000 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-12-16|12|660|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-1|13|365|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-2|13|443|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-3|13|493|Other deterministic changes|Whole body|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-4|13|532|Other deterministic changes|Whole body|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-5|13|570|Other deterministic changes|Whole body|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-6|13|612|Other deterministic changes|Whole body|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-7|13|626|Other deterministic changes|Whole body|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-8|13|633|Other deterministic changes|Lower respiratory system|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-9|13|666|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-10|13|668|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-11|13|682|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-12|13|692|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-13|13|704|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-14|13|708|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-15|13|725|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-16|13|725|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-17|13|726|Neoplasia malignant|Lower respiratory system|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-18|13|726|Neoplasia malignant|Lower respiratory system|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-19|13|727|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-20|13|787|Hyperplastic changes|Lower respiratory system|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-21|13|791|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-22|13|791|Hyperplastic changes|Lower respiratory system|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-23|13|825|Neoplasia malignant|Lower respiratory system|n/a|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-24|13|825|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-13|Rn-WL1350-WLM 1012,10-1 5/73|1| 77|Rn-222 gas|1012|working level months|Inhalation| Inhaled over 0.75 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-13-25|13|825|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-1|14|257|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-2|14|493|Other deterministic changes|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-3|14|571|Other deterministic changes|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-4|14|577|Other deterministic changes|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-5|14|577|Other deterministic changes|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-6|14|592|Other deterministic changes|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-7|14|599|Other deterministic changes|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-8|14|608|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-9|14|615|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-10|14|668|Other deterministic changes|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-11|14|689|Hyperplastic changes|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-12|14|690|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-13|14|714|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-14|14|720|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-15|14|724|Hyperplastic changes|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-16|14|732|Neoplasia malignant|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-17|14|733|Other deterministic changes|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-18|14|748|Other deterministic changes|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-19|14|761|Neoplasia malignant|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-20|14|773|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-21|14|781|Neoplasia malignant|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-22|14|788|Other deterministic changes|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-23|14|790|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-24|14|847|Hyperplastic changes|Lower respiratory system|n/a|
2-2-14|Rn-WL1050-WLM 1050,30-1 1/78|1| 77|Rn-222 gas|1050|working level months|Inhalation| Inhaled over 0.75 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-14-25|14|850|Neoplasia malignant|Reproductive system,MA: 0000404 - prostate gland|,MPATH: 268 - adenocarcinoma|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-1|15|282|Other deterministic changes|Lower respiratory system|n/a|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-2|15|502|Other deterministic changes|Lower respiratory system|n/a|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-3|15|509|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-4|15|544|Other deterministic changes|Lower respiratory system|n/a|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-5|15|597|Hyperplastic changes|Lower respiratory system|n/a|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-6|15|686|Hyperplastic changes|Lower respiratory system|n/a|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-7|15|686|Other deterministic changes|Lower respiratory system|n/a|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-8|15|686|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-9|15|709|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-10|15|716|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney| metastatic,MPATH: 549 - carcinoma|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-11|15|743|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-12|15|790|Neoplasia benign|Lower respiratory system|n/a|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-13|15|790|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-14|15|846|Other deterministic changes|Lower respiratory system|n/a|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-15|15|849|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-16|15|868|Neoplasia malignant|Adrenal gland  among endocrine systems| metastatic|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-17|15|868|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-18|15|870|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 219 - adnexal and skin appendage tumor|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-19|15|876|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-15|Rn-WL1200-WLM 1200,43-242,34 10/80|1| 77|Rn-222 gas|1200|working level months|Inhalation| Inhaled over 1 m at 1200 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-15-20|15|876|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-1|16|85|Other deterministic changes|Whole body|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-2|16|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-3|16|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-4|16|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-5|16|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-6|16|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-7|16|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-8|16|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-9|16|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-10|16|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-11|16|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-12|16|467|Other deterministic changes|Lower respiratory system|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-13|16|467|Hyperplastic changes|Lower respiratory system|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-14|16|590|Neoplasia malignant|Lower respiratory system|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-15|16|610|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-16|16|670|Other deterministic changes|Lower respiratory system|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-17|16|683|Other deterministic changes|Lower respiratory system|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-18|16|694|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-19|16|729|Other deterministic changes|Lower respiratory system|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-20|16|746|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-21|16|748|Neoplasia benign|Lower respiratory system|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-22|16|751|Other deterministic changes|Lower respiratory system|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-23|16|776|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-24|16|809|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-25|16|809|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-26|16|824|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-27|16|831|Hyperplastic changes|Lower respiratory system|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-28|16|831|Neoplasia malignant|Lower respiratory system|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-29|16|859|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-16|Rn-WL2500-WLM 1470,3-2 6-2 10/72|1| 91|Rn-222 gas|1470|working level months|Inhalation| Inhaled over 2 m at 2500 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +20 spont.death|2-2-16-30|16|890|Neoplasia malignant|Lower respiratory system|n/a|
2-2-17|Rn-WL1500-WLM 1500,42-8 80|1| 77|Rn-222 gas|1500|working level months|Inhalation| Inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-17-1|17|559|Other deterministic changes|Lower respiratory system|n/a|
2-2-17|Rn-WL1500-WLM 1500,42-8 80|1| 77|Rn-222 gas|1500|working level months|Inhalation| Inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-17-2|17|580|Hyperplastic changes|Lower respiratory system|n/a|
2-2-17|Rn-WL1500-WLM 1500,42-8 80|1| 77|Rn-222 gas|1500|working level months|Inhalation| Inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-17-3|17|580|Neoplasia malignant|Lower respiratory system|n/a|
2-2-17|Rn-WL1500-WLM 1500,42-8 80|1| 77|Rn-222 gas|1500|working level months|Inhalation| Inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-17-4|17|580|Neoplasia benign|Lower respiratory system|n/a|
2-2-17|Rn-WL1500-WLM 1500,42-8 80|1| 77|Rn-222 gas|1500|working level months|Inhalation| Inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-17-5|17|588|Other deterministic changes|Lower respiratory system|n/a|
2-2-17|Rn-WL1500-WLM 1500,42-8 80|1| 77|Rn-222 gas|1500|working level months|Inhalation| Inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-17-6|17|588|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-17|Rn-WL1500-WLM 1500,42-8 80|1| 77|Rn-222 gas|1500|working level months|Inhalation| Inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-17-7|17|590|Other deterministic changes|Lower respiratory system|n/a|
2-2-17|Rn-WL1500-WLM 1500,42-8 80|1| 77|Rn-222 gas|1500|working level months|Inhalation| Inhaled over 1 m at 1500 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-17-8|17|590|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-1|18|23|Other deterministic changes|Whole body|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-2|18|26|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-3|18|71|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-4|18|537|Other deterministic changes|Whole body|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-5|18|571|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-6|18|610|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-7|18|653|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-8|18|658|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-9|18|676|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-10|18|699|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-11|18|705|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-12|18|705|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-13|18|707|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-14|18|724|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-15|18|728|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-16|18|736|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-17|18|742|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-18|18|744|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-19|18|744|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-20|18|751|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-21|18|763|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-22|18|766|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-23|18|777|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-24|18|787|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-25|18|792|Hyperplastic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-26|18|811|Hyperplastic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-27|18|820|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-28|18|820|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-29|18|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-30|18|830|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-31|18|839|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-32|18|840|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-33|18|851|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-34|18|852|Hyperplastic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-35|18|888|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-36|18|888|Neoplasia malignant|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-37|18|890|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-38|18|897|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-39|18|917|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-40|18|923|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-41|18|936|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-42|18|936|Hyperplastic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-43|18|957|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-44|18|973|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-45|18|977|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-46|18|986|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-47|18|987|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-48|18|987|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-49|18|987|Other deterministic changes|Lower respiratory system|n/a|
2-2-18|Rn-WL1200-WLM 1600,11/79 not in book check|1| 274|Rn-222 gas|1600|working level months|Inhalation| Inhaled over 1 m at 1200 WL??|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-18-50|18|991|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-19|Rn-WL3000-WLM 1600,S57 G3T4/84|Sequence:1, Age:77,Type:Rn-222 gas,Quantity:1600,Unit:working level months,Application:Inhalation, Remarks:Inhaled over 4 m at 3000 WL|60 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-2-20|Rn-WL3000-WLM 1600,S52 G3R S51 3MT S51 G3F 10/83|Sequence:1, Age:77,Type:Rn-222 gas,Quantity:1600,Unit:working level months,Application:Inhalation, Remarks:Inhaled over 4 m at 3000 WL|190 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-2-21|Rn-WL3000-WLM 1600,S57 G1SP 4/84|Sequence:1, Age:77,Type:Rn-222 gas,Quantity:1600,Unit:working level months,Application:Inhalation, Remarks:Inhaled over 2 m at 3000 WL|61 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-2-21|Rn-WL3000-WLM 1600,S57 G1SP 4/84|Sequence:2, Age:159,Type:saline control,Quantity:1600,Unit:working level months,Application:Inhalation, Remarks:4 inhalation 30 days separated|61 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-1|22|433|Neoplasia benign|Lower respiratory system|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-2|22|459|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-3|22|479|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-4|22|480|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-5|22|480|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-6|22|492|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-7|22|504|Other deterministic changes|Whole body|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-8|22|547|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-9|22|556|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-10|22|570|Other deterministic changes|Whole body|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-11|22|585|Other deterministic changes|Whole body|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-12|22|594|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-13|22|596|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-14|22|622|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-15|22|623|Other deterministic changes|Whole body|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-16|22|664|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-17|22|703|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-18|22|705|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-19|22|710|Other deterministic changes|Whole body|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-20|22|712|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-21|22|728|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-22|22|745|Hyperplastic changes|Lower respiratory system|n/a|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-23|22|755|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-24|22|759|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-22|Rn-WL1350-WLM 1665,10-2 5/73|1| 77|Rn-222 gas|1665|working level months|Inhalation| Inhaled over 1.25 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|check groups Lifespan study|2-2-22-25|22|759|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-1|23|192|Other deterministic changes|Whole body|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-2|23|320|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-3|23|351|Other deterministic changes|Whole body|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-4|23|439|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-5|23|440|Other deterministic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-6|23|440|Neoplasia malignant|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-7|23|441|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-8|23|462|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-9|23|509|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-10|23|533|Other deterministic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-11|23|595|Neoplasia benign|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-12|23|603|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-13|23|630|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-14|23|636|Hyperplastic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-15|23|643|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-16|23|666|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-17|23|668|Hyperplastic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-18|23|668|Hyperplastic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-19|23|683|Hyperplastic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-20|23|694|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-21|23|694|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-22|23|694|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-23|23|696|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-24|23|699|Other deterministic changes|Whole body|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-25|23|702|Hyperplastic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-26|23|703|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-27|23|707|Other deterministic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-28|23|708|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-29|23|714|Hyperplastic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-30|23|728|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-31|23|729|Hyperplastic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-32|23|746|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-33|23|748|Hyperplastic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-34|23|757|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-35|23|765|Hyperplastic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-36|23|768|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-37|23|769|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-38|23|798|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-39|23|801|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-40|23|808|Neoplasia benign|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-41|23|808|Hyperplastic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-42|23|808|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-43|23|814|Hyperplastic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-44|23|814|Other deterministic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-45|23|814|Neoplasia benign|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-46|23|826|Neoplasia benign|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-47|23|878|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-48|23|883|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-49|23|883|Hyperplastic changes|Lower respiratory system|n/a|
2-2-23|Rn-WL1384-WLM 1800,16-1 3/75|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 2 m at 1384 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-23-50|23|883|Hyperplastic changes|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-1|24|451|Other deterministic changes|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-2|24|465|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-3|24|471|Other deterministic changes|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-4|24|475|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-5|24|500|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-6|24|503|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-7|24|515|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-8|24|515|Hyperplastic changes|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-9|24|535|Other deterministic changes|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-10|24|536|Hyperplastic changes|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-11|24|536|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-12|24|548|Hyperplastic changes|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-13|24|552|Other deterministic changes|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-14|24|552|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-15|24|566|Other deterministic changes|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-16|24|569|Hyperplastic changes|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-17|24|581|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-18|24|583|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-19|24|593|Hyperplastic changes|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-20|24|605|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-21|24|613|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-22|24|622|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-23|24|632|Neoplasia benign|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-24|24|643|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-25|24|653|Other deterministic changes|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-26|24|661|Other deterministic changes|Lower respiratory system|n/a|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-27|24|661|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-28|24|676|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| metastatic,MPATH: 278 - follicular adenocarcinoma|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-29|24|692|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-24|Rn-WL1350-WLM 1800,RN3-47 4/81|1| 77|Rn-222 gas|1800|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-24-30|24|734|Other deterministic changes|Whole body|n/a|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-1|25|439|Other deterministic changes|Lower respiratory system|n/a|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-2|25|618|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-3|25|651|Other deterministic changes|Lower respiratory system|n/a|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-4|25|698|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-5|25|750|Other deterministic changes|Lower respiratory system|n/a|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-6|25|757|Other deterministic changes|Lower respiratory system|n/a|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-7|25|765|Hyperplastic changes|Lower respiratory system|n/a|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-8|25|779|Other deterministic changes|Lower respiratory system|n/a|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-9|25|790|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-10|25|793|Neoplasia malignant|Lower respiratory system|n/a|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-11|25|793|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-12|25|793|Neoplasia malignant|Lower respiratory system|n/a|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-13|25|800|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-14|25|807|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-15|25|811|Other deterministic changes|Lower respiratory system|n/a|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-16|25|828|Other deterministic changes|Lower respiratory system|n/a|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-17|25|828|Other deterministic changes|Lower respiratory system|n/a|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-18|25|831|Other deterministic changes|Lower respiratory system|n/a|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-19|25|841|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-25|Rn-WL1500-WLM 1900,22-1 6/76|1| 213|Rn-222 gas|1900|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-25-20|25|866|Hyperplastic changes|Lower respiratory system|n/a|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-1|26|358|Other deterministic changes|Lower respiratory system|n/a|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-2|26|364|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-3|26|434|Neoplasia malignant|Lower respiratory system|n/a|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-4|26|488|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-5|26|534|Neoplasia malignant|Lower respiratory system|n/a|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-6|26|559|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-7|26|660|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-8|26|695|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-9|26|779|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-10|26|779|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle|,MPATH: 268 - adenocarcinoma|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-11|26|803|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-12|26|819|Hyperplastic changes|Lower respiratory system|n/a|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-13|26|824|Other deterministic changes|Lower respiratory system|n/a|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-14|26|835|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-15|26|852|Hyperplastic changes|Lower respiratory system|n/a|
2-2-26|Rn-WL1050-WLM 1960,33-1 12/78|1| 77|Rn-222 gas|1960|working level months|Inhalation| Inhaled over 2 m at 1050 WL|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-26-16|26|970|Neoplasia malignant|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-1|27|4|Other deterministic changes|Whole body|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-2|27|181|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-3|27|216|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-4|27|261|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-5|27|271|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-6|27|278|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-7|27|299|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-8|27|307|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-9|27|343|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-10|27|353|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-11|27|357|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-12|27|363|Hyperplastic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-13|27|364|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-14|27|408|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-15|27|414|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-16|27|436|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-17|27|453|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-18|27|455|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-19|27|455|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-20|27|456|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-21|27|460|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-22|27|490|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-23|27|516|Other deterministic changes|Lower respiratory system|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-24|27|556|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-2-27|Rn-WL1500-WLM 2000,B44-2 10/80|1| 77|Rn-222 gas|2000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-27-25|27|609|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-1|28|314|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-2|28|337|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-3|28|350|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-4|28|404|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-5|28|424|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-6|28|448|Other deterministic changes|Whole body|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-7|28|461|Other deterministic changes|Whole body|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-8|28|489|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-9|28|489|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-10|28|489|Other deterministic changes|Whole body|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-11|28|494|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-12|28|518|Other deterministic changes|Whole body|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-13|28|522|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-14|28|528|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-15|28|534|Neoplasia malignant|Integumentary system,MA: 0000151 - skin| metastatic,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-16|28|539|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-17|28|546|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-18|28|546|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-19|28|548|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-20|28|556|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-21|28|556|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-22|28|559|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-23|28|562|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-24|28|562|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-25|28|572|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-26|28|576|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-27|28|578|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-28|28|583|Other deterministic changes|Whole body|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-29|28|584|Other deterministic changes|Whole body|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-30|28|595|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-31|28|612|Neoplasia malignant|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-32|28|613|Neoplasia malignant|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-33|28|619|Neoplasia malignant|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-34|28|620|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-35|28|633|Other deterministic changes|Whole body|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-36|28|647|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-37|28|647|Other deterministic changes|Whole body|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-38|28|657|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-39|28|668|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-40|28|673|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-41|28|678|Other deterministic changes|Whole body|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-42|28|678|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-43|28|685|Other deterministic changes|Whole body|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-44|28|697|Neoplasia benign|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-45|28|707|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-46|28|721|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-47|28|728|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-48|28|734|Other deterministic changes|Whole body|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-49|28|738|Other deterministic changes|Whole body|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-50|28|742|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-51|28|747|Neoplasia malignant|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-52|28|753|Hyperplastic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-53|28|754|Neoplasia malignant|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-54|28|754|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-55|28|757|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-56|28|759|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-57|28|762|Hyperplastic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-58|28|763|Hyperplastic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-59|28|765|Neoplasia malignant|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-60|28|765|Neoplasia benign|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-61|28|779|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-62|28|780|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-63|28|780|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-64|28|783|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-65|28|785|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-66|28|786|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-67|28|791|Hyperplastic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-68|28|807|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-69|28|807|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-70|28|809|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-71|28|814|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-72|28|815|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-73|28|815|Neoplasia malignant|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-74|28|815|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-75|28|820|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-76|28|820|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-77|28|820|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-78|28|829|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-79|28|840|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-80|28|841|Neoplasia malignant|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-81|28|842|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-82|28|843|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-83|28|845|Neoplasia malignant|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-84|28|854|Hyperplastic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-85|28|856|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-86|28|861|Neoplasia malignant|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-87|28|864|Hyperplastic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-88|28|864|Neoplasia malignant|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-89|28|870|Other deterministic changes|Lower respiratory system|n/a|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-90|28|870|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-91|28|891|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-92|28|892|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-28|Rn-WL1050-WLM 2100,17-21 6/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|93 (93 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-28-93|28|904|Neoplasia malignant|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-1|29|264|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-2|29|264|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-3|29|264|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-4|29|265|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-5|29|266|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-6|29|274|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-7|29|274|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-8|29|274|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-9|29|284|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-10|29|291|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-11|29|292|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-12|29|309|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-13|29|312|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-14|29|313|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-15|29|313|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-16|29|316|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-17|29|322|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-18|29|322|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-19|29|329|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-20|29|329|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-21|29|329|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-22|29|342|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-23|29|344|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-24|29|354|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-25|29|363|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-26|29|390|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-27|29|393|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-28|29|398|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-29|29|414|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-30|29|431|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-31|29|431|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-32|29|434|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-33|29|434|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-34|29|440|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-35|29|473|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-36|29|476|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-37|29|504|Hyperplastic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-38|29|504|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-39|29|523|Hyperplastic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-40|29|560|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-41|29|560|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-42|29|579|Hyperplastic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-43|29|579|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-44|29|579|Hyperplastic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-45|29|579|Other deterministic changes|Lower respiratory system|n/a|
2-2-29|Rn-WL1050-WLM 2100,49-b 12/81|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 1050 WL|46 (46 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-29-46|29|579|Hyperplastic changes|Lower respiratory system|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-1|30|11|Other deterministic changes|Whole body|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-2|30|371|Other deterministic changes|Lower respiratory system|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-3|30|431|Other deterministic changes|Lower respiratory system|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-4|30|449|Other deterministic changes|Whole body|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-5|30|473|Other deterministic changes|Lower respiratory system|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-6|30|474|Other deterministic changes|Lower respiratory system|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-7|30|552|Other deterministic changes|Lower respiratory system|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-8|30|584|Other deterministic changes|Whole body|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-9|30|598|Other deterministic changes|Whole body|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-10|30|615|Other deterministic changes|Whole body|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-11|30|619|Other deterministic changes|Lower respiratory system|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-12|30|631|Other deterministic changes|Lower respiratory system|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-13|30|654|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-14|30|659|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-15|30|685|Other deterministic changes|Whole body|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-16|30|699|Hyperplastic changes|Lower respiratory system|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-17|30|700|Other deterministic changes|Lower respiratory system|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-18|30|703|Other deterministic changes|Lower respiratory system|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-19|30|713|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-20|30|713|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-21|30|714|Hyperplastic changes|Lower respiratory system|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-22|30|717|Hyperplastic changes|Lower respiratory system|n/a|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-23|30|717|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-24|30|724|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-30|Rn-WL1050-WLM 2100,17-3 9/76|1| 244|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-30-25|30|766|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-1|31|57|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-2|31|83|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-3|31|469|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-4|31|504|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-5|31|541|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-6|31|548|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-7|31|561|Other deterministic changes|Whole body|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-8|31|568|Other deterministic changes|Whole body|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-9|31|591|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-10|31|613|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-11|31|624|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-12|31|649|Neoplasia malignant|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-13|31|670|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-14|31|670|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-15|31|677|Other deterministic changes|Whole body|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-16|31|678|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-17|31|681|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-18|31|685|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-19|31|693|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-20|31|694|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-21|31|695|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-22|31|716|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-23|31|716|Other deterministic changes|Lower respiratory system|n/a|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-24|31|716|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-31|Rn-WL1050-WLM 2100,17-4 2/77|1| 365|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-31-25|31|750|Other deterministic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-1|32|522|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-2|32|522|Neoplasia benign|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-3|32|522|Other deterministic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-4|32|522|Other deterministic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-5|32|522|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-6|32|560|Other deterministic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-7|32|560|Other deterministic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-8|32|560|Neoplasia benign|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-9|32|560|Other deterministic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-10|32|560|Neoplasia benign|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-11|32|560|Hyperplastic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-12|32|574|Other deterministic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-13|32|574|Other deterministic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-14|32|575|Other deterministic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-15|32|576|Other deterministic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-16|32|577|Neoplasia malignant|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-17|32|577|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-18|32|578|Other deterministic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-19|32|581|Neoplasia malignant|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-20|32|582|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-21|32|583|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-22|32|584|Hyperplastic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-23|32|589|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-24|32|589|Neoplasia malignant|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-25|32|666|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-26|32|666|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-27|32|666|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-28|32|666|Other deterministic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-29|32|666|Neoplasia malignant|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-30|32|666|Neoplasia malignant|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-31|32|708|Neoplasia malignant|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-32|32|708|Neoplasia malignant|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-33|32|708|Neoplasia benign|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-34|32|708|Neoplasia malignant|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-35|32|708|Neoplasia malignant|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-36|32|708|Neoplasia malignant|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-37|32|744|Hyperplastic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-38|32|744|Hyperplastic changes|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-39|32|744|Neoplasia malignant|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-40|32|744|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-41|32|744|Neoplasia benign|Lower respiratory system|n/a|
2-2-32|Rn-WL1050-WLM 2100,19-9b 1/76|1| 153|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 2 m at 1050 WL|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Sacrifice after one year|2-2-32-42|32|744|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-1|33|69|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-2|33|71|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-3|33|71|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-4|33|187|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-5|33|192|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-6|33|195|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-7|33|202|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-8|33|208|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-9|33|226|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-10|33|242|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-11|33|243|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-12|33|246|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-13|33|260|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-14|33|292|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-15|33|301|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-16|33|346|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-17|33|357|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-18|33|382|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-19|33|403|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-20|33|463|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-21|33|476|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-22|33|486|Other deterministic changes|Whole body|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-23|33|493|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-24|33|501|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-25|33|512|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-26|33|552|Hyperplastic changes|Lower respiratory system|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-27|33|609|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-28|33|609|Hyperplastic changes|Lower respiratory system|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-29|33|657|Hyperplastic changes|Lower respiratory system|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-30|33|721|Neoplasia benign|Lower respiratory system|n/a|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-31|33|747|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-32|33|748|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-33|Rn-WL3600-WLM 2100,12 + 13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-33-33|33|754|Hyperplastic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-1|34|60|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-2|34|60|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-3|34|60|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-4|34|60|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-5|34|60|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-6|34|60|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-7|34|206|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-8|34|206|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-9|34|206|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-10|34|206|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-11|34|206|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-12|34|206|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-13|34|258|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-14|34|258|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-15|34|258|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-16|34|258|Hyperplastic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-17|34|258|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-18|34|258|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-19|34|306|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-20|34|306|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-21|34|306|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-22|34|306|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-23|34|306|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-24|34|306|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-25|34|306|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-26|34|306|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-27|34|478|Other deterministic changes|Whole body|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-28|34|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-29|34|484|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-30|34|484|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-31|34|484|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-32|34|487|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-33|34|494|Other deterministic changes|Whole body|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-34|34|494|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-35|34|495|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-36|34|495|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-37|34|495|Other deterministic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-38|34|516|Other deterministic changes|Whole body|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-39|34|518|Hyperplastic changes|Lower respiratory system|n/a|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-40|34|526|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-41|34|541|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-42|34|543|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-43|34|544|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-44|34|548|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-45|34|557|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-46|34|557|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-47|34|558|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-48|34|561|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-49|34|561|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-50|34|566|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-34|Rn-WL3600-WLM 2100,13 11/73|1| 77|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1.5 m at 3600 WL|51 (51 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|2-2-34-51|34|568|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-35|Rn-WL3600-WLM 2100,11/73|1| 305|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-35-1|35|568|Other deterministic changes|Whole body|n/a|
2-2-35|Rn-WL3600-WLM 2100,11/73|1| 305|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-35-2|35|650|Other deterministic changes|Whole body|n/a|
2-2-35|Rn-WL3600-WLM 2100,11/73|1| 305|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-35-3|35|685|Other deterministic changes|Whole body|n/a|
2-2-35|Rn-WL3600-WLM 2100,11/73|1| 305|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-35-4|35|785|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-35|Rn-WL3600-WLM 2100,11/73|1| 305|Rn-222 gas|2100|working level months|Inhalation| Inhaled over 1 m at 3600 WL|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Adult|Lifespan study|2-2-35-5|35|785|Other deterministic changes|Whole body|n/a|
2-2-36|Rn-WL2500-WLM 2200,3-3 72|1| 77|Rn-222 gas|2200|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Serial sacrifice|2-2-36-1|36|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-36|Rn-WL2500-WLM 2200,3-3 72|1| 77|Rn-222 gas|2200|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Serial sacrifice|2-2-36-2|36|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-36|Rn-WL2500-WLM 2200,3-3 72|1| 77|Rn-222 gas|2200|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Serial sacrifice|2-2-36-3|36|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-36|Rn-WL2500-WLM 2200,3-3 72|1| 77|Rn-222 gas|2200|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Serial sacrifice|2-2-36-4|36|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-36|Rn-WL2500-WLM 2200,3-3 72|1| 77|Rn-222 gas|2200|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Serial sacrifice|2-2-36-5|36|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-36|Rn-WL2500-WLM 2200,3-3 72|1| 77|Rn-222 gas|2200|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Serial sacrifice|2-2-36-6|36|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-36|Rn-WL2500-WLM 2200,3-3 72|1| 77|Rn-222 gas|2200|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Serial sacrifice|2-2-36-7|36|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-36|Rn-WL2500-WLM 2200,3-3 72|1| 77|Rn-222 gas|2200|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Serial sacrifice|2-2-36-8|36|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-36|Rn-WL2500-WLM 2200,3-3 72|1| 77|Rn-222 gas|2200|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Serial sacrifice|2-2-36-9|36|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-37|Rn-WL1200-WLM 2240,36-3 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-37-1|37|331|Other deterministic changes|Lower respiratory system|n/a|
2-2-37|Rn-WL1200-WLM 2240,36-3 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-37-2|37|461|Other deterministic changes|Lower respiratory system|n/a|
2-2-37|Rn-WL1200-WLM 2240,36-3 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-37-3|37|546|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-2-37|Rn-WL1200-WLM 2240,36-3 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-37-4|37|566|Other deterministic changes|Lower respiratory system|n/a|
2-2-37|Rn-WL1200-WLM 2240,36-3 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-37-5|37|596|Other deterministic changes|Lower respiratory system|n/a|
2-2-37|Rn-WL1200-WLM 2240,36-3 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-37-6|37|679|Other deterministic changes|Lower respiratory system|n/a|
2-2-37|Rn-WL1200-WLM 2240,36-3 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-37-7|37|731|Neoplasia benign|Lower respiratory system|n/a|
2-2-37|Rn-WL1200-WLM 2240,36-3 4/79|1| 77|Rn-222 gas|2240|working level months|Inhalation| Inhaled over 2.5 m at 1200 WL|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-37-8|37|735|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-1|38|270|Other deterministic changes|Whole body|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-2|38|323|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-3|38|326|Other deterministic changes|Lower respiratory system|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-4|38|361|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-5|38|365|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-6|38|400|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-7|38|412|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-8|38|418|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-9|38|453|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-10|38|453|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-11|38|472|Other deterministic changes|Whole body|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-12|38|492|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-13|38|542|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-14|38|544|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-15|38|560|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-16|38|579|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-17|38|586|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-18|38|636|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-19|38|644|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-20|38|647|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-21|38|659|Hyperplastic changes|Lower respiratory system|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-22|38|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-23|38|710|Neoplasia malignant|Lower respiratory system|n/a|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-24|38|775|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-38|Rn-WL1350-WLM 2430,10-3 5/73|1| 77|Rn-222 gas|2430|working level months|Inhalation| Inhaled over 1.5 m at 1350 WL|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-38-25|38|777|Hyperplastic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-1|39|204|Other deterministic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-2|39|275|Other deterministic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-3|39|303|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-4|39|339|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-5|39|364|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-6|39|389|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-7|39|392|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-8|39|394|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-9|39|424|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-10|39|425|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-11|39|440|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-12|39|447|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-13|39|457|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-14|39|457|Other deterministic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-15|39|459|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-16|39|464|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-17|39|473|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-18|39|473|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-19|39|477|Hyperplastic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-20|39|480|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-21|39|483|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-22|39|483|Neoplasia benign|Lower respiratory system,MA: 0000415 - lung|,MPATH: 240 - hemangioma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-23|39|485|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-24|39|494|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-25|39|494|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-26|39|495|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-27|39|498|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-28|39|498|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-29|39|502|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-30|39|504|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-31|39|507|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-32|39|507|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-33|39|508|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-34|39|512|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-35|39|516|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-36|39|520|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-37|39|522|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-38|39|529|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-39|39|531|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-40|39|534|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-41|39|534|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-42|39|543|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-43|39|543|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-44|39|547|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-45|39|551|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-46|39|552|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-47|39|557|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-48|39|557|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-49|39|559|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-50|39|564|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-51|39|565|Hyperplastic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-52|39|565|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-53|39|568|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-54|39|575|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-55|39|592|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-56|39|593|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-57|39|594|Hyperplastic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-58|39|598|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-59|39|600|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-60|39|602|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-61|39|602|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-62|39|602|Other deterministic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-63|39|607|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-64|39|607|Hyperplastic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-65|39|610|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-66|39|610|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-67|39|613|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-68|39|613|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-69|39|614|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-70|39|615|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-71|39|625|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-72|39|627|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-73|39|631|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-74|39|632|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-75|39|635|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-76|39|639|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-77|39|641|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-78|39|643|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-79|39|648|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-80|39|648|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-81|39|649|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-82|39|649|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-83|39|659|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-84|39|659|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-85|39|662|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-86|39|662|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-87|39|662|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-88|39|664|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-89|39|666|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-90|39|666|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-91|39|666|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-92|39|670|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-93|39|672|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-94|39|679|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-95|39|680|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-96|39|683|Other deterministic changes|Whole body|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-97|39|683|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-98|39|685|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-99|39|685|Neoplasia benign|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-100|39|686|Hyperplastic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-101|39|686|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-102|39|687|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-103|39|688|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-104|39|690|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-105|39|690|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-106|39|690|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-107|39|693|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-108|39|693|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-109|39|695|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-110|39|695|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-111|39|698|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-112|39|698|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-113|39|698|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-114|39|700|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-115|39|704|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-116|39|705|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-117|39|707|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-118|39|718|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-119|39|718|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-120|39|718|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-121|39|719|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-122|39|720|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-123|39|721|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-124|39|722|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-125|39|723|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-126|39|724|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-127|39|725|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-128|39|725|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-129|39|726|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-130|39|727|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-131|39|728|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-132|39|728|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-133|39|729|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-134|39|730|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-135|39|730|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-136|39|730|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-137|39|732|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-138|39|732|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-139|39|732|Hyperplastic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-140|39|732|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-141|39|732|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-142|39|732|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-143|39|736|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-144|39|739|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-145|39|740|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-146|39|740|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-147|39|740|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-148|39|740|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-149|39|742|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-150|39|743|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-151|39|746|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-152|39|751|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-153|39|754|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-154|39|754|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-155|39|754|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-156|39|754|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-157|39|754|Neoplasia malignant|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-158|39|754|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-159|39|754|Hyperplastic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-160|39|760|Hyperplastic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-161|39|760|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-162|39|760|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-163|39|760|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-164|39|760|Hyperplastic changes|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-165|39|760|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-166|39|760|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-167|39|760|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-168|39|760|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-169|39|760|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-170|39|760|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-171|39|760|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-172|39|760|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-173|39|760|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-174|39|760|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-175|39|760|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-176|39|760|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-177|39|760|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-178|39|760|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-179|39|760|Neoplasia benign|Lower respiratory system|n/a|
2-2-39|Rn-WL1050-WLM 2800,14 2/74|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 1050 WL|180 (180 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-39-180|39|760|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-1|40|206|Other deterministic changes|Whole body|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-2|40|206|Other deterministic changes|Whole body|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-3|40|244|Other deterministic changes|Whole body|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-4|40|271|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-5|40|271|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-6|40|271|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-7|40|271|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-8|40|271|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-9|40|271|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-10|40|271|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-11|40|271|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-12|40|271|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-13|40|271|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-14|40|276|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-15|40|276|Hyperplastic changes|Lower respiratory system|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-16|40|276|Other deterministic changes|Lower respiratory system|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-17|40|276|Hyperplastic changes|Lower respiratory system|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-18|40|276|Other deterministic changes|Lower respiratory system|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-19|40|276|Other deterministic changes|Lower respiratory system|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-20|40|276|Hyperplastic changes|Lower respiratory system|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-21|40|276|Other deterministic changes|Lower respiratory system|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-22|40|276|Neoplasia benign|Lower respiratory system|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-23|40|276|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-24|40|317|Other deterministic changes|Whole body|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-25|40|356|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-26|40|407|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-27|40|414|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-28|40|460|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-29|40|466|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-30|40|466|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-31|40|466|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-32|40|466|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-33|40|466|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-34|40|466|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-35|40|466|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-36|40|466|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-37|40|466|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-38|40|466|Neoplasia benign|Lower respiratory system|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-39|40|484|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-40|40|499|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-41|40|503|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-42|40|526|Other deterministic changes|Whole body|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-43|40|534|Other deterministic changes|Whole body|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-44|40|545|Other deterministic changes|Whole body|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-45|40|561|Other deterministic changes|Whole body|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-46|40|562|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-47|40|562|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-48|40|562|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-49|40|562|Neoplasia benign|Lower respiratory system|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-50|40|562|Hyperplastic changes|Lower respiratory system|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-51|40|562|Hyperplastic changes|Lower respiratory system|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-52|40|568|Other deterministic changes|Whole body|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-53|40|575|Other deterministic changes|Whole body|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-54|40|600|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-55|40|636|Neoplasia malignant|Lower respiratory system|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-56|40|674|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-57|40|682|Other deterministic changes|Whole body|n/a|
2-2-40|Rn-WL4800-WLM 2800,7-1 9-3b 2/73|1| 77|Rn-222 gas|2800|working level months|Inhalation| Inhaled over 1 m at 4800 WL|58 (58 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-40-58|40|703|Other deterministic changes|Whole body|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-1|41|4|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-2|41|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-3|41|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-4|41|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-5|41|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-6|41|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-7|41|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-8|41|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-9|41|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-10|41|392|Hyperplastic changes|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-11|41|392|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-12|41|417|Other deterministic changes|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-13|41|427|Other deterministic changes|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-14|41|432|Other deterministic changes|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-15|41|467|Hyperplastic changes|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-16|41|467|Neoplasia malignant|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-17|41|512|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-18|41|601|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-19|41|648|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-20|41|649|Neoplasia malignant|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-21|41|659|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-22|41|680|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-23|41|733|Other deterministic changes|Whole body|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-24|41|774|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-25|41|776|Hyperplastic changes|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-26|41|776|Neoplasia malignant|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-27|41|784|Hyperplastic changes|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-28|41|786|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-29|41|806|Neoplasia malignant|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-30|41|814|Neoplasia malignant|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-31|41|818|Neoplasia malignant|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-32|41|832|Hyperplastic changes|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-33|41|836|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-34|41|846|Hyperplastic changes|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-35|41|846|Neoplasia malignant|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-36|41|855|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-37|41|860|Hyperplastic changes|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-38|41|863|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-39|41|863|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-40|41|863|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-41|41|870|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-42|41|875|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-43|41|876|Neoplasia malignant|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-44|41|876|Neoplasia malignant|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-45|41|889|Neoplasia malignant|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-46|41|889|Hyperplastic changes|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-47|41|889|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-48|41|889|Neoplasia malignant|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-49|41|889|Neoplasia malignant|Lower respiratory system|n/a|
2-2-41|Rn-WL2500-WLM 2970,3-4 6-3 72|1| 91|Rn-222 gas|2970|working level months|Inhalation| Inhaled over 2 m at 2500 WL|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|10 Serial sacrifice +40 spont.death|2-2-41-50|41|889|Neoplasia malignant|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-1|42|197|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-2|42|388|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-3|42|416|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-4|42|450|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-5|42|455|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-6|42|457|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-7|42|489|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-8|42|521|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-9|42|552|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-10|42|560|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-11|42|575|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-12|42|578|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-13|42|588|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-14|42|602|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-15|42|622|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-16|42|636|Hyperplastic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-17|42|638|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-18|42|645|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-19|42|651|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-20|42|651|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-21|42|652|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-22|42|654|Neoplasia malignant|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-23|42|654|Neoplasia malignant|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-24|42|654|Hyperplastic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-25|42|654|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-26|42|657|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-27|42|657|Other deterministic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-28|42|660|Hyperplastic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-29|42|695|Neoplasia malignant|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-30|42|713|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-31|42|728|Hyperplastic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-32|42|743|Hyperplastic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-33|42|776|Hyperplastic changes|Lower respiratory system|n/a|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-34|42|780|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-42|Rn-WL1500-WLM 3000,29-1 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 1.5 m at 1500 WL|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-42-35|42|815|Hyperplastic changes|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-1|43|258|Other deterministic changes|Whole body|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-2|43|276|Other deterministic changes|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-3|43|336|Other deterministic changes|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-4|43|442|Other deterministic changes|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-5|43|471|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-6|43|510|Neoplasia malignant|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-7|43|521|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-8|43|525|Hyperplastic changes|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-9|43|525|Hyperplastic changes|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-10|43|547|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-11|43|560|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-12|43|561|Neoplasia malignant|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-13|43|561|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-14|43|561|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-15|43|562|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-16|43|596|Other deterministic changes|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-17|43|601|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-18|43|601|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-19|43|602|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-20|43|622|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-21|43|647|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-22|43|650|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-23|43|651|Neoplasia malignant|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-24|43|657|Hyperplastic changes|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-25|43|657|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-26|43|657|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-27|43|663|Hyperplastic changes|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-28|43|672|Hyperplastic changes|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-29|43|675|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-30|43|694|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-31|43|700|Hyperplastic changes|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-32|43|701|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-33|43|734|Neoplasia malignant|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-34|43|741|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-35|43|755|Neoplasia malignant|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-36|43|757|Hyperplastic changes|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-37|43|757|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-38|43|757|Neoplasia malignant|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-39|43|776|Neoplasia malignant|Lower respiratory system|n/a|
2-2-43|Rn-WL1500-WLM 3000,29-3 12/77|1| 77|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 7 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-43-40|43|813|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-1|44|344|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 218 - neoplasm|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-2|44|375|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-3|44|380|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-4|44|380|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-5|44|384|Neoplasia malignant|Heart among cardiovascular system,MA: 0000072 - heart|,MPATH: 511 - Myeloproliferation (genetic)|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-6|44|393|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-7|44|408|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-8|44|414|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-9|44|421|Other deterministic changes|Whole body|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-10|44|429|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-11|44|430|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-12|44|439|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-13|44|443|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-14|44|449|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-15|44|456|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-16|44|456|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-17|44|463|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-18|44|467|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-19|44|477|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-20|44|503|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-21|44|514|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-22|44|548|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-23|44|567|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-24|44|574|Hyperplastic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-25|44|577|Neoplasia malignant|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-26|44|577|Hyperplastic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-27|44|577|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-28|44|577|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-29|44|580|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-30|44|580|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-31|44|583|Other deterministic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-32|44|583|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-33|44|591|Hyperplastic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-34|44|631|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-35|44|631|Hyperplastic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-36|44|657|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-37|44|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-38|44|713|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-39|44|738|Hyperplastic changes|Lower respiratory system|n/a|
2-2-44|Rn-WL1500-WLM 3000,29-2 6/78|1| 183|Rn-222 gas|3000|working level months|Inhalation| Inhaled over 0.5 m at 1500 WL|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-44-40|44|738|Hyperplastic changes|Lower respiratory system|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-1|45|214|Other deterministic changes|Whole body|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-2|45|312|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-3|45|316|Hyperplastic changes|Lower respiratory system|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-4|45|351|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-5|45|361|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-6|45|369|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-7|45|400|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-8|45|401|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-9|45|409|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-10|45|427|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-11|45|438|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-12|45|444|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-13|45|444|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-14|45|453|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-15|45|479|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-16|45|480|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-17|45|487|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-18|45|509|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-19|45|521|Hyperplastic changes|Lower respiratory system|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-20|45|577|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-21|45|594|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-22|45|600|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-23|45|647|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-24|45|664|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-25|45|665|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-45|Rn-WL1350-WLM 3100,10-4 5/73|1| 77|Rn-222 gas|3100|working level months|Inhalation| Inhaled over 2 m at 1350 WL|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-45-26|45|690|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-1|46|293|Other deterministic changes|Whole body|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-2|46|300|Other deterministic changes|Whole body|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-3|46|310|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-4|46|314|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-5|46|331|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-6|46|331|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-7|46|331|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-8|46|331|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-9|46|331|Other deterministic changes|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-10|46|331|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-11|46|331|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-12|46|331|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-13|46|331|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-14|46|331|Hyperplastic changes|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-15|46|346|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-16|46|359|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-17|46|380|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-18|46|380|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-19|46|380|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-20|46|380|Hyperplastic changes|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-21|46|380|Neoplasia benign|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-22|46|380|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-23|46|380|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-24|46|380|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-25|46|380|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-26|46|380|Neoplasia malignant|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-27|46|392|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-28|46|393|Other deterministic changes|Whole body|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-29|46|408|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-30|46|408|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-31|46|414|Neoplasia systemic|Haematolymphatic system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-32|46|426|Other deterministic changes|Whole body|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-33|46|443|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-34|46|443|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-35|46|443|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-36|46|443|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-37|46|443|Neoplasia benign|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-38|46|443|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-39|46|443|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-40|46|443|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-41|46|443|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-42|46|443|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-43|46|449|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-44|46|458|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-45|46|466|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-46|46|466|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-47|46|466|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-48|46|466|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-49|46|466|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-50|46|466|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-51|46|466|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-52|46|466|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-53|46|466|Hyperplastic changes|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-54|46|466|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-55|46|487|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-56|46|491|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-57|46|506|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-58|46|506|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-59|46|506|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-60|46|506|Hyperplastic changes|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-61|46|506|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-62|46|506|Hyperplastic changes|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-63|46|506|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-64|46|506|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-65|46|506|Hyperplastic changes|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-66|46|506|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-67|46|506|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-68|46|510|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-69|46|527|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-70|46|545|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-71|46|546|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-72|46|546|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-73|46|563|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-74|46|563|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-75|46|564|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-76|46|568|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-77|46|568|Neoplasia malignant|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-78|46|568|Hyperplastic changes|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-79|46|568|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-80|46|568|Hyperplastic changes|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-81|46|568|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-82|46|568|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-83|46|568|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-84|46|568|Neoplasia benign|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-85|46|568|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-86|46|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-87|46|574|Neoplasia malignant|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-88|46|584|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-89|46|595|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-90|46|604|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-91|46|660|Hyperplastic changes|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-92|46|660|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-93|46|699|Neoplasia malignant|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-94|46|701|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-95|46|701|Hyperplastic changes|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-96|46|701|Neoplasia malignant|Lower respiratory system|n/a|
2-2-46|Rn-WL5400-WLM 3150,11-1,1,2 6/73|1| 77|Rn-222 gas|3150|working level months|Inhalation| Inhaled over 1.5 m at 5400 WL|97 (97 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-46-97|46|701|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-1|47|6|Hyperplastic changes|Lower respiratory system|n/a|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-2|47|316|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-3|47|451|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-4|47|472|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-5|47|473|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-6|47|474|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-7|47|487|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 446 - squamous cell carcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-8|47|500|Neoplasia malignant|Bloodvessels among cardiovascular system| metastatic|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-9|47|506|Neoplasia systemic|Haematolymphatic system|n/a|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-10|47|509|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-11|47|517|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| metastatic,MPATH: 278 - follicular adenocarcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-12|47|566|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-13|47|639|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-14|47|648|Neoplasia malignant|Lower respiratory system|n/a|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-15|47|650|Neoplasia benign|Lower respiratory system|n/a|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-16|47|688|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-17|47|713|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|1| 77|Rn-222 gas|4000|working level months|Inhalation| Inhaled over 2 m|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-18|47|720|Neoplasia malignant|Lower respiratory system|n/a|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-1|47|6|Hyperplastic changes|Lower respiratory system|n/a|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-2|47|316|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-3|47|451|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-4|47|472|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-5|47|473|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-6|47|474|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-7|47|487|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 446 - squamous cell carcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-8|47|500|Neoplasia malignant|Bloodvessels among cardiovascular system| metastatic|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-9|47|506|Neoplasia systemic|Haematolymphatic system|n/a|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-10|47|509|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-11|47|517|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| metastatic,MPATH: 278 - follicular adenocarcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-12|47|566|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-13|47|639|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-14|47|648|Neoplasia malignant|Lower respiratory system|n/a|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-15|47|650|Neoplasia benign|Lower respiratory system|n/a|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-16|47|688|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-17|47|713|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-47|Rn-WL?-WLM 4000,4/84|2| 107|saline control|0|working level months|Inhalation| inhaled|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-47-18|47|720|Neoplasia malignant|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-1|48|362|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-2|48|362|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-3|48|362|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-4|48|362|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-5|48|362|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-6|48|362|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-7|48|362|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-8|48|362|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-9|48|362|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-10|48|467|Hyperplastic changes|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-11|48|467|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-12|48|544|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-13|48|560|Other deterministic changes|Whole body|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-14|48|580|Hyperplastic changes|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-15|48|601|Neoplasia malignant|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-16|48|608|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-17|48|613|Neoplasia malignant|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-18|48|620|Hyperplastic changes|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-19|48|620|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-20|48|639|Neoplasia malignant|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-21|48|653|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-22|48|684|Neoplasia malignant|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-23|48|684|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-24|48|684|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-25|48|715|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-26|48|721|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-27|48|743|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-28|48|748|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-29|48|764|Neoplasia malignant|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-30|48|783|Neoplasia malignant|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-31|48|792|Neoplasia benign|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-32|48|792|Neoplasia malignant|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-33|48|792|Neoplasia benign|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-34|48|792|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-35|48|818|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-36|48|818|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-37|48|825|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-38|48|825|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-39|48|825|Neoplasia malignant|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-40|48|831|Neoplasia benign|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-41|48|831|Hyperplastic changes|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-42|48|850|Neoplasia benign|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-43|48|852|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-44|48|863|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-45|48|870|Neoplasia benign|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-46|48|889|Neoplasia malignant|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-47|48|889|Hyperplastic changes|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-48|48|889|Neoplasia malignant|Lower respiratory system|n/a|
2-2-48|Rn-WL2500-WLM 4500,3-5 6-4 72|1| 91|Rn-222 gas|4500|working level months|Inhalation| Inhaled over 2 m at 2500 WL|49 (49 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|9 serial sacrifice +40 spont.death|2-2-48-49|48|889|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-1|49|48|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-2|49|63|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-3|49|69|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-4|49|71|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-5|49|176|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-6|49|176|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-7|49|176|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-8|49|176|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-9|49|178|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-10|49|186|Hyperplastic changes|Lower respiratory system|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-11|49|189|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-12|49|193|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-13|49|194|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-14|49|196|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-15|49|207|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-16|49|216|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-17|49|217|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-18|49|236|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-19|49|250|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-20|49|251|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-21|49|258|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-22|49|258|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-23|49|258|Hyperplastic changes|Lower respiratory system|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-24|49|258|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-25|49|259|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-26|49|259|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-27|49|259|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-28|49|264|Hyperplastic changes|Lower respiratory system|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-29|49|264|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-30|49|265|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-31|49|272|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-32|49|276|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-33|49|285|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-34|49|285|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-35|49|285|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-36|49|286|Hyperplastic changes|Lower respiratory system|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-37|49|287|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-38|49|287|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-39|49|287|Hyperplastic changes|Lower respiratory system|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-40|49|291|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-41|49|301|Hyperplastic changes|Lower respiratory system|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-42|49|301|Neoplasia benign|Lower respiratory system|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-43|49|307|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-44|49|316|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-45|49|318|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-46|49|318|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-47|49|321|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-48|49|331|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-49|49|332|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-50|49|341|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-51|49|349|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-52|49|353|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-53|49|355|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-54|49|358|Hyperplastic changes|Lower respiratory system|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-55|49|359|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-56|49|362|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-57|49|378|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-58|49|381|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-59|49|386|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-60|49|391|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-61|49|394|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-62|49|399|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-63|49|399|Hyperplastic changes|Lower respiratory system|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-64|49|408|Other deterministic changes|Whole body|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-65|49|408|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-66|49|443|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-67|49|450|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-68|49|456|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-69|49|456|Hyperplastic changes|Lower respiratory system|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-70|49|456|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-71|49|456|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-72|49|456|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-73|49|456|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-74|49|456|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-75|49|456|Neoplasia benign|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-76|49|456|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-77|49|456|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-78|49|456|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-49|Rn-WL4800-WLM 5600,7-2 9-3,4,5 2/73|1| 77|Rn-222 gas|5600|working level months|Inhalation| Inhaled over 3 m at 4800 WL|79 (79 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-49-79|49|456|Hyperplastic changes|Lower respiratory system|n/a|
2-2-50|Rn-WL2500-WLM 6900,3-5 72|1| 91|Rn-222 gas|6900|working level months|Inhalation| Inhaled over 2 m at 2500 WL|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-50-1|50|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-50|Rn-WL2500-WLM 6900,3-5 72|1| 91|Rn-222 gas|6900|working level months|Inhalation| Inhaled over 2 m at 2500 WL|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-50-2|50|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-50|Rn-WL2500-WLM 6900,3-5 72|1| 91|Rn-222 gas|6900|working level months|Inhalation| Inhaled over 2 m at 2500 WL|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-50-3|50|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-50|Rn-WL2500-WLM 6900,3-5 72|1| 91|Rn-222 gas|6900|working level months|Inhalation| Inhaled over 2 m at 2500 WL|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-50-4|50|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-50|Rn-WL2500-WLM 6900,3-5 72|1| 91|Rn-222 gas|6900|working level months|Inhalation| Inhaled over 2 m at 2500 WL|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-50-5|50|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-50|Rn-WL2500-WLM 6900,3-5 72|1| 91|Rn-222 gas|6900|working level months|Inhalation| Inhaled over 2 m at 2500 WL|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-50-6|50|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-50|Rn-WL2500-WLM 6900,3-5 72|1| 91|Rn-222 gas|6900|working level months|Inhalation| Inhaled over 2 m at 2500 WL|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-50-7|50|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-50|Rn-WL2500-WLM 6900,3-5 72|1| 91|Rn-222 gas|6900|working level months|Inhalation| Inhaled over 2 m at 2500 WL|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-50-8|50|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-50|Rn-WL2500-WLM 6900,3-5 72|1| 91|Rn-222 gas|6900|working level months|Inhalation| Inhaled over 2 m at 2500 WL|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-50-9|50|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-50|Rn-WL2500-WLM 6900,3-5 72|1| 91|Rn-222 gas|6900|working level months|Inhalation| Inhaled over 2 m at 2500 WL|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-50-10|50|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-50|Rn-WL2500-WLM 6900,3-5 72|1| 91|Rn-222 gas|6900|working level months|Inhalation| Inhaled over 2 m at 2500 WL|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-50-11|50|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-50|Rn-WL2500-WLM 6900,3-5 72|1| 91|Rn-222 gas|6900|working level months|Inhalation| Inhaled over 2 m at 2500 WL|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-50-12|50|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-51|Rn-WL2500-WLM 7650,3-7 72|1| 91|Rn-222 gas|7650|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-51-1|51|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-51|Rn-WL2500-WLM 7650,3-7 72|1| 91|Rn-222 gas|7650|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-51-2|51|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-51|Rn-WL2500-WLM 7650,3-7 72|1| 91|Rn-222 gas|7650|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-51-3|51|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-51|Rn-WL2500-WLM 7650,3-7 72|1| 91|Rn-222 gas|7650|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-51-4|51|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-51|Rn-WL2500-WLM 7650,3-7 72|1| 91|Rn-222 gas|7650|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-51-5|51|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-51|Rn-WL2500-WLM 7650,3-7 72|1| 91|Rn-222 gas|7650|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-51-6|51|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-51|Rn-WL2500-WLM 7650,3-7 72|1| 91|Rn-222 gas|7650|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-51-7|51|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-51|Rn-WL2500-WLM 7650,3-7 72|1| 91|Rn-222 gas|7650|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-51-8|51|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-51|Rn-WL2500-WLM 7650,3-7 72|1| 91|Rn-222 gas|7650|working level months|Inhalation| Inhaled over 2 m at 2500 WL|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|serial sacrifice|2-2-51-9|51|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-1|52|50|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-2|52|64|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-3|52|176|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-4|52|178|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-5|52|182|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-6|52|182|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-7|52|185|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-8|52|185|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-9|52|185|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-10|52|189|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-11|52|204|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-12|52|212|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-13|52|216|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-14|52|216|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-15|52|222|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-16|52|222|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-17|52|222|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-18|52|222|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-19|52|254|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-20|52|255|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-21|52|259|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-22|52|259|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-23|52|260|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-24|52|263|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-25|52|265|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-26|52|265|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-27|52|265|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-28|52|266|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-29|52|272|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-30|52|272|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-31|52|276|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-32|52|277|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-33|52|280|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-34|52|283|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-35|52|285|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-36|52|291|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-37|52|298|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-38|52|305|Other deterministic changes|Whole body|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-39|52|318|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-40|52|318|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-41|52|318|Hyperplastic changes|Lower respiratory system|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-42|52|318|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-43|52|318|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-44|52|318|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-45|52|318|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-46|52|318|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-47|52|318|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-52|Rn-WL4800-WLM 8400,7-3 2/73|1| 77|Rn-222 gas|8400|working level months|Inhalation| Inhaled over 4.5 m at 4800 WL|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-52-48|52|318|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-1|53|236|Other deterministic changes|Whole body|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-2|53|236|Other deterministic changes|Whole body|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-3|53|302|Other deterministic changes|Lower respiratory system|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-4|53|310|Other deterministic changes|Lower respiratory system|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-5|53|402|Other deterministic changes|Whole body|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-6|53|402|Other deterministic changes|Whole body|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-7|53|402|Other deterministic changes|Whole body|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-8|53|402|Hyperplastic changes|Lower respiratory system|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-9|53|404|Hyperplastic changes|Lower respiratory system|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-10|53|452|Hyperplastic changes|Lower respiratory system|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-11|53|457|Hyperplastic changes|Lower respiratory system|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-12|53|482|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-13|53|489|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-14|53|512|Hyperplastic changes|Lower respiratory system|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-15|53|512|Hyperplastic changes|Lower respiratory system|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-16|53|527|Hyperplastic changes|Lower respiratory system|n/a|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-17|53|542|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-18|53|542|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-19|53|542|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-53|Rn-WL2500-WLM 9250,2-1 1/70|1| 91|Rn-222 gas|9250|working level months|Inhalation| Inhaled over 2 m at 2500 WL|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-53-20|53|542|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-1|54|56|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-2|54|57|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-3|54|69|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-4|54|176|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-5|54|176|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-6|54|176|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-7|54|178|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-8|54|179|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-9|54|183|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-10|54|192|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-11|54|195|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-12|54|196|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-13|54|196|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-14|54|196|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-15|54|196|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-16|54|204|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-17|54|205|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-18|54|208|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-19|54|208|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-20|54|209|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-21|54|222|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-22|54|225|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-23|54|225|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-24|54|236|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-25|54|237|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-26|54|243|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-27|54|243|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-28|54|244|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-29|54|250|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-30|54|251|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-31|54|251|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-32|54|251|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-33|54|251|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-34|54|251|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-35|54|251|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-36|54|252|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-37|54|252|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-38|54|257|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-39|54|259|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-40|54|259|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-41|54|259|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-42|54|261|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-43|54|261|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-44|54|262|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-45|54|262|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-46|54|263|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-47|54|263|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-48|54|263|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-49|54|265|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-50|54|265|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-51|54|265|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-52|54|265|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-53|54|269|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-54|54|269|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-55|54|270|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-56|54|270|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-57|54|272|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-58|54|276|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-59|54|277|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-60|54|280|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-61|54|280|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-62|54|281|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-63|54|281|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-64|54|281|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-65|54|281|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-66|54|284|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-67|54|286|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-68|54|287|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-69|54|287|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-70|54|290|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-71|54|292|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-72|54|292|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-73|54|293|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-74|54|293|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-75|54|299|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-76|54|301|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-77|54|311|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-78|54|314|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-79|54|314|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-80|54|314|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-81|54|316|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-82|54|316|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-83|54|316|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-84|54|316|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-85|54|316|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-86|54|316|Other deterministic changes|Whole body|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-87|54|321|Neoplasia benign|Lower respiratory system|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-88|54|321|Neoplasia benign|Lower respiratory system|n/a|
2-2-54|Rn-WL4800-WLM 11200,7-4,5, 2/73|1| 77|Rn-222 gas|11200|working level months|Inhalation| Inhaled over 6 m at 4800 WL|89 (89 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-2-54-89|54|324|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-1|55|123|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-2|55|192|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-3|55|192|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-4|55|245|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-5|55|250|Neoplasia unclassified|Central nervous system among nervous system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-6|55|257|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-7|55|263|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract| benign,MPATH: 549 - carcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-8|55|339|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-9|55|371|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-10|55|383|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-11|55|390|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract| metastatic,MPATH: 549 - carcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-12|55|391|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-13|55|402|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-14|55|412|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-15|55|439|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland| benign,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-16|55|447|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-17|55|452|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-18|55|458|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-19|55|458|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-20|55|458|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-21|55|458|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-22|55|458|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-23|55|458|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-24|55|458|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-25|55|475|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-26|55|482|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland| benign,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-27|55|488|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-28|55|490|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-29|55|493|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-30|55|500|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-31|55|501|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-32|55|504|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-33|55|507|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-34|55|521|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-35|55|522|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-36|55|531|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-37|55|532|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-38|55|535|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-39|55|539|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-40|55|539|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-41|55|564|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-42|55|566|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-43|55|566|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-44|55|570|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-45|55|571|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-46|55|573|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-47|55|577|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-48|55|577|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-49|55|578|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-50|55|578|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-51|55|581|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-52|55|588|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-53|55|592|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-54|55|599|Neoplasia unclassified|Central nervous system among nervous system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-55|55|599|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-56|55|605|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-57|55|615|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-58|55|617|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland| benign,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-59|55|619|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-60|55|621|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-61|55|623|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-62|55|630|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-63|55|630|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-64|55|630|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-65|55|633|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-66|55|633|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-67|55|636|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-68|55|640|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-69|55|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-70|55|642|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-71|55|651|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-72|55|651|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-73|55|651|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-74|55|655|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-75|55|662|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-76|55|669|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-77|55|669|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-78|55|671|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-79|55|675|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-80|55|675|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-81|55|676|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-82|55|676|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-83|55|677|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-84|55|677|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-85|55|679|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-86|55|686|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-87|55|686|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-88|55|689|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-89|55|696|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-90|55|696|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-91|55|696|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-92|55|700|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-93|55|700|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-94|55|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-95|55|705|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-96|55|705|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-97|55|707|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-98|55|711|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-99|55|713|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| metastatic,MPATH: 513 - Lymphoid neoplasms|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-100|55|717|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-101|55|717|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-102|55|718|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-103|55|718|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-104|55|718|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-105|55|720|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-106|55|720|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-107|55|720|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system| benign,MPATH: 551 - sarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-108|55|721|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ| metastatic,MPATH: 428 - rhabdomyosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-109|55|721|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-110|55|728|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland| benign,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-111|55|731|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system| benign,MPATH: 551 - sarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-112|55|731|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-113|55|731|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-114|55|732|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-115|55|732|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-116|55|733|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-117|55|733|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-118|55|733|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-119|55|738|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-120|55|738|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-121|55|738|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-122|55|739|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-123|55|739|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-124|55|741|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-125|55|741|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-126|55|741|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-127|55|742|Neoplasia unclassified|Nervous system and special sense organs,MA: 0002565 - sebaceous gland|,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-128|55|742|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland| benign,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-129|55|742|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-130|55|745|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-131|55|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-132|55|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-133|55|749|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-134|55|749|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-135|55|752|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-136|55|754|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-137|55|754|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-138|55|756|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland| benign,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-139|55|756|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-140|55|760|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-141|55|760|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-142|55|760|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland| benign,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-143|55|764|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-144|55|764|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-145|55|764|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-146|55|766|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system| benign,MPATH: 551 - sarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-147|55|766|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-148|55|768|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland| benign,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-149|55|770|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-150|55|773|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-151|55|773|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-152|55|773|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-153|55|775|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-154|55|777|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-155|55|780|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-156|55|780|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-157|55|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-158|55|780|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland| benign,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-159|55|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-160|55|783|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-161|55|783|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-162|55|784|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system| benign,MPATH: 551 - sarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-163|55|787|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-164|55|787|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-165|55|788|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-166|55|794|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-167|55|796|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland| benign,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-168|55|796|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-169|55|797|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-170|55|797|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| metastatic,MPATH: 513 - Lymphoid neoplasms|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-171|55|797|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-172|55|798|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-173|55|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-174|55|798|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-175|55|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-176|55|801|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-177|55|801|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-178|55|801|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-179|55|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-180|55|803|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-181|55|803|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-182|55|804|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-183|55|804|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-184|55|805|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-185|55|808|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-186|55|808|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-187|55|808|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-188|55|808|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-189|55|809|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-190|55|809|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-191|55|809|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-192|55|810|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-193|55|810|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-194|55|810|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-195|55|811|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-196|55|815|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-197|55|816|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-198|55|816|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-199|55|816|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-200|55|816|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-201|55|817|Neoplasia malignant|Integumentary system,MA: 0000151 - skin| metastatic,MPATH: 446 - squamous cell carcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-202|55|817|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-203|55|817|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-204|55|817|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-205|55|818|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland| benign,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-206|55|818|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-207|55|818|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|,MPATH: 218 - neoplasm|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-208|55|819|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-209|55|819|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-210|55|822|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-211|55|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-212|55|824|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-213|55|824|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-214|55|825|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-215|55|825|Neoplasia malignant|Other local manifestations and miscellaneus| metastatic|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-216|55|826|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system| benign,MPATH: 551 - sarcoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-217|55|826|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-218|55|829|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-219|55|829|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-220|55|829|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-221|55|830|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-222|55|833|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-223|55|833|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-224|55|836|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-225|55|836|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-226|55|838|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-227|55|838|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-228|55|840|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-229|55|840|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-230|55|840|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-231|55|850|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-232|55|850|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-233|55|850|Neoplasia malignant|Other local manifestations and miscellaneus| metastatic|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-234|55|850|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-235|55|850|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-236|55|850|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-237|55|851|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-238|55|851|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| metastatic,MPATH: 513 - Lymphoid neoplasms|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-239|55|851|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-240|55|851|Neoplasia malignant|Bloodvessels among cardiovascular system| metastatic|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-241|55|852|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-242|55|853|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-243|55|854|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-244|55|854|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-245|55|857|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-246|55|857|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-247|55|857|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-248|55|857|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-249|55|858|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-250|55|858|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-251|55|858|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-252|55|858|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-253|55|859|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-254|55|859|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-255|55|859|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-256|55|859|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-257|55|859|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-258|55|859|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-259|55|866|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-260|55|866|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-261|55|867|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-262|55|867|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-263|55|868|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-264|55|871|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-265|55|871|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-266|55|871|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-267|55|872|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-268|55|872|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-269|55|874|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-270|55|878|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-271|55|878|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-272|55|878|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-273|55|878|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-274|55|878|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-275|55|878|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-276|55|879|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-277|55|879|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-278|55|879|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| metastatic,MPATH: 513 - Lymphoid neoplasms|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-279|55|879|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-280|55|879|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-281|55|880|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-282|55|880|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-283|55|882|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-284|55|885|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-285|55|885|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-286|55|885|Other deterministic changes|Whole body|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-287|55|886|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-288|55|887|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-289|55|887|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-290|55|887|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-291|55|889|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-292|55|889|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-293|55|889|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-294|55|889|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-295|55|892|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-296|55|892|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-297|55|892|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-298|55|892|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-299|55|892|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-300|55|892|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-301|55|894|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-302|55|894|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-303|55|894|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-304|55|894|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-305|55|899|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-306|55|899|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-307|55|900|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-308|55|900|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-309|55|900|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-310|55|900|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-311|55|903|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-312|55|903|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-313|55|903|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-314|55|903|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-315|55|903|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-316|55|906|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-317|55|906|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-318|55|907|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-319|55|907|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-320|55|908|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-321|55|910|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-322|55|910|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-323|55|910|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-324|55|910|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-325|55|913|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-326|55|913|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-327|55|913|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-328|55|914|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-329|55|914|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-330|55|914|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-331|55|916|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-332|55|916|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-333|55|916|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-334|55|917|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-335|55|917|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-336|55|921|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-337|55|921|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-338|55|921|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-339|55|922|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-340|55|922|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-341|55|927|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-342|55|927|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-343|55|927|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-344|55|927|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-345|55|927|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-346|55|927|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-347|55|927|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-348|55|929|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-349|55|929|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-350|55|931|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-351|55|931|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-352|55|935|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-353|55|935|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-354|55|935|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-355|55|935|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-356|55|936|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-357|55|936|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-358|55|936|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-359|55|938|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-360|55|938|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-361|55|941|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-362|55|941|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-363|55|941|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-364|55|942|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-365|55|942|Other deterministic changes|Whole body|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-366|55|942|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-367|55|942|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-368|55|943|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-369|55|943|Other deterministic changes|Whole body|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-370|55|943|Other deterministic changes|Whole body|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-371|55|944|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-372|55|948|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-373|55|952|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-374|55|952|Other deterministic changes|Whole body|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-375|55|952|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-376|55|955|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-377|55|955|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-378|55|955|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-379|55|956|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-380|55|958|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-381|55|958|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-382|55|958|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-383|55|958|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-384|55|962|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-385|55|964|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-386|55|964|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-387|55|964|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-388|55|964|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-389|55|965|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-390|55|965|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-391|55|966|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-392|55|966|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-393|55|969|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-394|55|969|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-395|55|969|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-396|55|969|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-397|55|969|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-398|55|969|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-399|55|971|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-400|55|972|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-401|55|972|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-402|55|977|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-403|55|977|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-404|55|977|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-405|55|979|Other deterministic changes|Whole body|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-406|55|979|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-407|55|979|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-408|55|983|Other deterministic changes|Whole body|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-409|55|983|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-410|55|983|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-411|55|983|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-412|55|986|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-413|55|986|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-414|55|987|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-415|55|987|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-416|55|987|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-417|55|990|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-418|55|993|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-419|55|993|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-420|55|994|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-421|55|994|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-422|55|997|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-423|55|1001|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-424|55|1001|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-425|55|1001|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-426|55|1004|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-427|55|1004|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-428|55|1004|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-429|55|1004|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-430|55|1006|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-431|55|1006|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-432|55|1007|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-433|55|1007|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-434|55|1007|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-435|55|1011|Neoplasia malignant|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-436|55|1011|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-437|55|1012|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-438|55|1013|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-439|55|1014|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-440|55|1015|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-441|55|1015|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-442|55|1018|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-443|55|1020|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-444|55|1020|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-445|55|1021|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-446|55|1025|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-447|55|1027|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-448|55|1032|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-449|55|1032|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-450|55|1032|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-451|55|1035|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-452|55|1035|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-453|55|1035|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-454|55|1036|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-455|55|1036|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-456|55|1036|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-457|55|1039|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-458|55|1039|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-459|55|1040|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-460|55|1040|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-461|55|1041|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-462|55|1041|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-463|55|1042|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-464|55|1042|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-465|55|1043|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-466|55|1043|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-467|55|1046|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-468|55|1046|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-469|55|1048|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-470|55|1048|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-471|55|1049|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-472|55|1049|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-473|55|1050|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-474|55|1050|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-475|55|1053|Hyperplastic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-476|55|1053|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-477|55|1055|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-478|55|1055|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-479|55|1057|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-480|55|1057|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-481|55|1060|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-482|55|1060|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-483|55|1061|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-484|55|1061|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-485|55|1063|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-486|55|1063|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-487|55|1064|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-488|55|1064|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-489|55|1067|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-490|55|1067|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-491|55|1068|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-492|55|1068|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-493|55|1069|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-494|55|1069|Neoplasia benign|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-495|55|1070|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-496|55|1070|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-497|55|1071|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-498|55|1071|Other deterministic changes|Lower respiratory system|n/a|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-499|55|1074|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-55|Rn-WL2-WLM 25,6/89|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 2 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-55-500|55|1074|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-1|56|1|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-2|56|1|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-3|56|1|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-4|56|1|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-5|56|1|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-6|56|1|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-7|56|1|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-8|56|1|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 409 - fibrous histiocytoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-9|56|1|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-10|56|1|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-11|56|1|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-12|56|1|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-13|56|1|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-14|56|176|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-15|56|195|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-16|56|307|Other deterministic changes|Whole body|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-17|56|319|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-18|56|340|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-19|56|351|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-20|56|391|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-21|56|396|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-22|56|404|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-23|56|414|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-24|56|450|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-25|56|461|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-26|56|490|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-27|56|494|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-28|56|494|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-29|56|494|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-30|56|496|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-31|56|496|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-32|56|496|Other deterministic changes|Whole body|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-33|56|526|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-34|56|530|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-35|56|533|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-36|56|538|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-37|56|543|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-38|56|543|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-39|56|552|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-40|56|554|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| metastatic,MPATH: 409 - fibrous histiocytoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-41|56|558|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-42|56|564|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-43|56|572|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-44|56|579|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-45|56|582|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system| benign,MPATH: 551 - sarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-46|56|582|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-47|56|588|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-48|56|588|Neoplasia malignant|Liver among hepato-pancreatic system diseases| metastatic|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-49|56|592|Other deterministic changes|Whole body|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-50|56|592|Other deterministic changes|Whole body|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-51|56|592|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-52|56|593|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-53|56|594|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-54|56|594|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-55|56|599|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-56|56|599|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-57|56|600|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-58|56|608|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-59|56|609|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-60|56|610|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-61|56|615|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-62|56|620|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-63|56|620|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland| benign,MPATH: 218 - neoplasm|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-64|56|623|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-65|56|624|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-66|56|624|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-67|56|624|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-68|56|627|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-69|56|627|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-70|56|628|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-71|56|628|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| metastatic,MPATH: 409 - fibrous histiocytoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-72|56|631|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-73|56|638|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-74|56|641|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-75|56|641|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-76|56|643|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-77|56|643|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-78|56|643|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-79|56|645|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-80|56|645|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-81|56|652|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-82|56|656|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-83|56|656|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-84|56|656|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-85|56|659|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-86|56|665|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-87|56|669|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-88|56|670|Neoplasia malignant|Adrenal gland  among endocrine systems| benign|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-89|56|670|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-90|56|671|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-91|56|673|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-92|56|676|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-93|56|677|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-94|56|678|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-95|56|680|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-96|56|686|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system| benign,MPATH: 551 - sarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-97|56|686|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-98|56|687|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-99|56|691|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-100|56|691|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-101|56|691|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-102|56|694|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-103|56|697|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen| benign,MPATH: 242 - hemangiosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-104|56|697|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-105|56|697|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-106|56|697|Other deterministic changes|Whole body|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-107|56|697|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-108|56|698|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-109|56|700|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-110|56|701|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-111|56|707|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-112|56|711|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-113|56|711|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-114|56|711|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-115|56|714|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-116|56|718|Neoplasia malignant|Liver among hepato-pancreatic system diseases| metastatic|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-117|56|718|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-118|56|718|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-119|56|719|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-120|56|720|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-121|56|720|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-122|56|722|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-123|56|722|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-124|56|722|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-125|56|725|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-126|56|726|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-127|56|726|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-128|56|728|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-129|56|732|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-130|56|732|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-131|56|733|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-132|56|734|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-133|56|735|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-134|56|735|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-135|56|735|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-136|56|736|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-137|56|736|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-138|56|736|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-139|56|739|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-140|56|739|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-141|56|740|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-142|56|740|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-143|56|740|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-144|56|740|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-145|56|740|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-146|56|741|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-147|56|741|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-148|56|743|Neoplasia malignant|Bloodvessels among cardiovascular system| benign|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-149|56|743|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-150|56|746|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-151|56|746|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-152|56|746|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-153|56|748|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-154|56|748|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-155|56|748|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-156|56|749|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-157|56|753|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-158|56|753|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-159|56|754|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-160|56|754|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-161|56|754|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-162|56|754|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-163|56|754|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-164|56|755|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-165|56|756|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-166|56|761|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-167|56|761|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-168|56|761|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-169|56|761|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-170|56|762|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-171|56|762|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-172|56|762|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-173|56|762|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-174|56|763|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-175|56|764|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-176|56|767|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-177|56|767|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-178|56|767|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-179|56|768|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-180|56|768|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-181|56|771|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-182|56|771|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-183|56|774|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-184|56|774|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-185|56|774|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-186|56|774|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-187|56|776|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-188|56|778|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-189|56|778|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-190|56|778|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-191|56|781|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-192|56|781|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-193|56|781|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-194|56|782|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-195|56|782|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-196|56|782|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-197|56|784|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-198|56|784|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-199|56|785|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-200|56|785|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-201|56|785|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-202|56|785|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-203|56|785|Neoplasia malignant|Bloodvessels among cardiovascular system| benign|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-204|56|788|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-205|56|789|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-206|56|789|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-207|56|790|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland| benign,MPATH: 218 - neoplasm|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-208|56|790|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-209|56|790|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-210|56|790|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-211|56|792|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-212|56|792|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-213|56|797|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-214|56|797|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-215|56|797|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-216|56|797|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract| metastatic,MPATH: 549 - carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-217|56|797|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-218|56|798|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-219|56|798|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-220|56|798|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-221|56|798|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-222|56|802|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-223|56|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-224|56|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-225|56|803|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-226|56|804|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-227|56|804|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-228|56|805|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-229|56|805|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-230|56|806|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-231|56|806|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-232|56|809|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-233|56|809|Neoplasia malignant|Adrenal gland  among endocrine systems| metastatic|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-234|56|809|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-235|56|809|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-236|56|809|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-237|56|809|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-238|56|810|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-239|56|812|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-240|56|812|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-241|56|812|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-242|56|812|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-243|56|812|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-244|56|813|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-245|56|816|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-246|56|817|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-247|56|817|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-248|56|817|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-249|56|818|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-250|56|818|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-251|56|818|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-252|56|818|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-253|56|819|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-254|56|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-255|56|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-256|56|823|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-257|56|823|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-258|56|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-259|56|824|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-260|56|824|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-261|56|824|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-262|56|824|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-263|56|824|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-264|56|825|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-265|56|825|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-266|56|825|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-267|56|825|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-268|56|826|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-269|56|826|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-270|56|826|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-271|56|826|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-272|56|827|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-273|56|827|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-274|56|827|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-275|56|827|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-276|56|827|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-277|56|827|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-278|56|830|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-279|56|830|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-280|56|831|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-281|56|832|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-282|56|834|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-283|56|834|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-284|56|834|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-285|56|834|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-286|56|837|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-287|56|837|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-288|56|837|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-289|56|838|Neoplasia benign|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-290|56|840|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-291|56|840|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-292|56|840|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-293|56|840|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-294|56|840|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-295|56|841|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-296|56|841|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 409 - fibrous histiocytoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-297|56|845|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-298|56|845|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-299|56|845|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-300|56|845|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-301|56|846|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-302|56|846|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-303|56|846|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-304|56|847|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-305|56|847|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-306|56|849|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-307|56|849|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-308|56|849|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-309|56|849|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-310|56|849|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-311|56|849|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-312|56|849|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-313|56|852|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-314|56|853|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-315|56|853|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-316|56|853|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-317|56|854|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-318|56|854|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-319|56|856|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-320|56|856|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-321|56|856|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-322|56|859|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-323|56|859|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-324|56|859|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-325|56|859|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-326|56|860|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-327|56|860|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-328|56|861|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-329|56|861|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-330|56|861|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-331|56|861|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-332|56|862|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-333|56|862|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-334|56|863|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-335|56|863|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-336|56|863|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-337|56|863|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-338|56|866|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-339|56|866|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-340|56|868|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-341|56|868|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-342|56|868|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-343|56|868|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-344|56|868|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-345|56|869|Neoplasia malignant|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-346|56|869|Neoplasia malignant|Lower digestive tract,MA: 0000353 - stomach|,MPATH: 549 - carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-347|56|869|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-348|56|870|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-349|56|870|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-350|56|873|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-351|56|874|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system| benign,MPATH: 551 - sarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-352|56|875|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-353|56|875|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-354|56|875|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-355|56|876|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-356|56|876|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-357|56|877|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-358|56|880|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-359|56|880|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-360|56|880|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-361|56|880|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-362|56|880|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-363|56|881|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-364|56|881|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-365|56|881|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-366|56|881|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-367|56|882|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-368|56|882|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-369|56|882|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-370|56|882|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-371|56|883|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney| metastatic,MPATH: 549 - carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-372|56|884|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-373|56|884|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-374|56|884|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-375|56|884|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-376|56|884|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-377|56|884|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-378|56|887|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-379|56|888|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 551 - sarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-380|56|888|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-381|56|888|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-382|56|890|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-383|56|890|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-384|56|891|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-385|56|894|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-386|56|894|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-387|56|896|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-388|56|896|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-389|56|897|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-390|56|898|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-391|56|901|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-392|56|901|Neoplasia malignant|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-393|56|901|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-394|56|902|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-395|56|902|Neoplasia malignant|Bloodvessels among cardiovascular system| benign|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-396|56|902|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-397|56|902|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-398|56|902|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-399|56|902|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-400|56|903|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-401|56|904|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-402|56|904|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-403|56|908|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-404|56|908|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-405|56|911|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-406|56|911|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland| benign,MPATH: 549 - carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-407|56|911|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-408|56|911|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-409|56|911|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-410|56|912|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-411|56|917|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-412|56|917|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-413|56|917|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-414|56|917|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-415|56|918|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-416|56|919|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-417|56|919|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-418|56|919|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-419|56|922|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-420|56|922|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-421|56|922|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-422|56|923|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland| metastatic,MPATH: 218 - neoplasm|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-423|56|923|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-424|56|923|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-425|56|924|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-426|56|924|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-427|56|925|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-428|56|925|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-429|56|925|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-430|56|932|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-431|56|933|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-432|56|933|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-433|56|933|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-434|56|936|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-435|56|936|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-436|56|936|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-437|56|936|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-438|56|936|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-439|56|937|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-440|56|937|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-441|56|937|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-442|56|938|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-443|56|938|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-444|56|938|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-445|56|941|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-446|56|941|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-447|56|941|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-448|56|943|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-449|56|945|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-450|56|945|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-451|56|946|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-452|56|946|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-453|56|947|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-454|56|957|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-455|56|958|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-456|56|961|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-457|56|965|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-458|56|965|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-459|56|966|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-460|56|967|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-461|56|967|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-462|56|967|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-463|56|971|Neoplasia malignant|Heart among cardiovascular system,MA: 0000072 - heart|,MPATH: 511 - Myeloproliferation (genetic)|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-464|56|973|Neoplasia malignant|Adrenal gland  among endocrine systems| benign|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-465|56|975|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-466|56|978|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-467|56|978|Neoplasia malignant|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-468|56|978|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-469|56|978|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-470|56|979|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-471|56|980|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-472|56|982|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-473|56|982|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-474|56|982|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-475|56|982|Neoplasia benign|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-476|56|982|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-477|56|987|Neoplasia benign|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-478|56|987|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-479|56|988|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-480|56|988|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-481|56|989|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-482|56|992|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-483|56|992|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-484|56|992|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-485|56|993|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-486|56|993|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-487|56|993|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-488|56|994|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-489|56|994|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-490|56|994|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-491|56|995|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-492|56|995|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 219 - adnexal and skin appendage tumor|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-493|56|995|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-494|56|995|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-495|56|996|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-496|56|996|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-497|56|996|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-498|56|996|Hyperplastic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-499|56|999|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-500|56|999|Other deterministic changes|Lower respiratory system|n/a|
2-2-56|Rn-WL100-WLM 25,RN3-45 12/80|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 3.5 m at 100 WL|501 (501 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-56-501|56|999|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-1|57|38|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-2|57|249|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-3|57|286|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-4|57|348|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-5|57|397|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-6|57|397|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-7|57|397|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-8|57|399|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-9|57|399|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-10|57|403|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-11|57|406|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-12|57|412|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-13|57|427|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-14|57|438|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-15|57|438|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-16|57|440|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-17|57|452|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-18|57|453|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-19|57|459|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-20|57|459|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-21|57|460|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-22|57|474|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-23|57|476|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-24|57|487|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-25|57|487|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-26|57|489|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-27|57|501|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-28|57|509|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-29|57|511|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-30|57|516|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-31|57|526|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-32|57|529|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-33|57|536|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-34|57|536|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-35|57|536|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-36|57|550|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-37|57|550|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-38|57|552|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-39|57|552|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-40|57|552|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-41|57|558|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-42|57|558|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-43|57|564|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-44|57|567|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-45|57|567|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-46|57|571|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-47|57|572|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-48|57|572|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-49|57|578|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-50|57|578|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-51|57|578|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-52|57|581|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-53|57|582|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-54|57|585|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-55|57|585|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-56|57|589|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-57|57|593|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-58|57|594|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-59|57|599|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-60|57|599|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-61|57|599|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-62|57|599|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-63|57|599|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-64|57|600|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-65|57|601|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-66|57|602|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-67|57|606|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-68|57|607|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-69|57|607|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-70|57|608|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-71|57|608|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-72|57|608|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-73|57|609|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-74|57|609|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-75|57|616|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-76|57|617|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-77|57|617|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-78|57|622|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-79|57|624|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-80|57|627|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-81|57|627|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-82|57|627|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-83|57|628|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-84|57|630|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-85|57|631|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-86|57|631|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-87|57|634|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-88|57|634|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-89|57|634|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-90|57|636|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-91|57|637|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-92|57|640|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-93|57|640|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-94|57|640|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-95|57|640|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-96|57|640|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-97|57|640|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-98|57|640|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-99|57|641|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-100|57|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-101|57|642|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-102|57|642|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-103|57|642|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-104|57|643|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-105|57|644|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-106|57|644|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-107|57|644|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-108|57|649|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-109|57|649|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-110|57|649|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-111|57|649|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-112|57|649|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-113|57|651|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-114|57|656|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-115|57|656|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-116|57|656|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-117|57|656|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-118|57|656|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-119|57|656|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-120|57|656|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-121|57|658|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-122|57|661|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-123|57|661|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-124|57|661|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-125|57|661|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-126|57|661|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-127|57|662|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-128|57|662|Hyperplastic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-129|57|663|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-130|57|663|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-131|57|664|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-132|57|665|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-133|57|665|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-134|57|668|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-135|57|668|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-136|57|668|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-137|57|668|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-138|57|668|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-139|57|668|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-140|57|670|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-141|57|671|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-142|57|672|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-143|57|672|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-144|57|672|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-145|57|672|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-146|57|675|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-147|57|676|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-148|57|676|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-149|57|676|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-150|57|676|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-151|57|676|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-152|57|679|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-153|57|679|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-154|57|682|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-155|57|682|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-156|57|682|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-157|57|682|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-158|57|682|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-159|57|682|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-160|57|684|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-161|57|684|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-162|57|685|Hyperplastic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-163|57|685|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-164|57|685|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-165|57|689|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-166|57|689|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-167|57|689|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-168|57|689|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-169|57|690|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-170|57|691|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-171|57|691|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-172|57|691|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-173|57|691|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-174|57|692|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-175|57|692|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-176|57|692|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-177|57|696|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-178|57|696|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-179|57|696|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-180|57|696|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-181|57|696|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-182|57|696|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-183|57|696|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-184|57|697|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-185|57|699|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-186|57|699|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-187|57|699|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-188|57|700|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-189|57|700|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-190|57|700|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-191|57|703|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-192|57|703|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-193|57|703|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-194|57|703|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-195|57|703|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-196|57|703|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-197|57|704|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-198|57|704|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-199|57|704|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-200|57|704|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-201|57|705|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-202|57|705|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-203|57|705|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-204|57|706|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-205|57|707|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-206|57|708|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-207|57|710|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-208|57|710|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-209|57|710|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-210|57|710|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-211|57|710|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-212|57|710|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-213|57|710|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-214|57|711|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-215|57|712|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-216|57|713|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-217|57|714|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-218|57|714|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-219|57|714|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-220|57|714|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-221|57|717|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-222|57|717|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-223|57|717|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-224|57|717|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-225|57|717|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-226|57|717|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-227|57|721|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-228|57|724|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-229|57|724|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-230|57|726|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-231|57|726|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-232|57|726|Neoplasia malignant|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-233|57|726|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-234|57|726|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-235|57|727|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-236|57|727|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-237|57|731|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-238|57|731|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-239|57|731|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-240|57|731|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-241|57|731|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-242|57|731|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-243|57|731|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-244|57|731|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-245|57|731|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-246|57|731|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-247|57|732|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-248|57|733|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-249|57|734|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-250|57|734|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-251|57|734|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-252|57|735|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-253|57|738|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-254|57|738|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-255|57|738|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-256|57|738|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-257|57|738|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-258|57|738|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-259|57|738|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-260|57|738|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-261|57|740|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-262|57|740|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-263|57|741|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-264|57|741|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-265|57|741|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-266|57|742|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-267|57|742|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-268|57|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-269|57|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-270|57|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-271|57|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-272|57|745|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-273|57|747|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-274|57|747|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-275|57|747|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-276|57|748|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-277|57|748|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-278|57|749|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-279|57|749|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-280|57|749|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-281|57|753|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-282|57|753|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-283|57|753|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-284|57|753|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-285|57|753|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-286|57|754|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-287|57|754|Neoplasia benign|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-288|57|756|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-289|57|756|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-290|57|756|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-291|57|759|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-292|57|759|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-293|57|759|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-294|57|760|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-295|57|760|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-296|57|761|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-297|57|761|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-298|57|762|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-299|57|762|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-300|57|762|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-301|57|763|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-302|57|766|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-303|57|766|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-304|57|766|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-305|57|766|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-306|57|766|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-307|57|766|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-308|57|766|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-309|57|767|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-310|57|767|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-311|57|769|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-312|57|769|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-313|57|770|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-314|57|770|Hyperplastic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-315|57|773|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-316|57|773|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-317|57|773|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-318|57|773|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-319|57|774|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-320|57|774|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-321|57|775|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-322|57|775|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-323|57|775|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-324|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-325|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-326|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-327|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-328|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-329|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-330|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-331|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-332|57|780|Neoplasia malignant|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-333|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-334|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-335|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-336|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-337|57|780|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-338|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-339|57|780|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-340|57|781|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-341|57|782|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-342|57|783|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-343|57|783|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-344|57|783|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-345|57|783|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-346|57|784|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-347|57|787|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-348|57|787|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-349|57|787|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-350|57|788|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-351|57|791|Neoplasia malignant|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-352|57|791|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-353|57|791|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-354|57|791|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-355|57|791|Neoplasia malignant|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-356|57|794|Other deterministic changes|Whole body|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-357|57|794|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-358|57|794|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-359|57|794|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-360|57|794|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-361|57|795|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-362|57|796|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-363|57|797|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-364|57|798|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-365|57|798|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-366|57|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-367|57|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-368|57|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-369|57|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-370|57|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-371|57|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-372|57|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-373|57|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-374|57|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-375|57|804|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-376|57|804|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-377|57|804|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-378|57|805|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-379|57|805|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-380|57|806|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-381|57|808|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-382|57|808|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-383|57|808|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-384|57|808|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-385|57|808|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-386|57|808|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-387|57|808|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-388|57|809|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-389|57|809|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-390|57|809|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-391|57|810|Neoplasia malignant|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-392|57|810|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-393|57|810|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-394|57|810|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-395|57|811|Hyperplastic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-396|57|812|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-397|57|815|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-398|57|815|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-399|57|815|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-400|57|815|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-401|57|815|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-402|57|815|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-403|57|815|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-404|57|815|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-405|57|815|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-406|57|816|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-407|57|817|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-408|57|817|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-409|57|818|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-410|57|819|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-411|57|822|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-412|57|822|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-413|57|822|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-414|57|822|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-415|57|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-416|57|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-417|57|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-418|57|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-419|57|824|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-420|57|824|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-421|57|824|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-422|57|826|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-423|57|829|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-424|57|829|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-425|57|829|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-426|57|829|Hyperplastic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-427|57|829|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-428|57|829|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-429|57|830|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-430|57|830|Hyperplastic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-431|57|830|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-432|57|831|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-433|57|832|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-434|57|832|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-435|57|832|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-436|57|833|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-437|57|833|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-438|57|836|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-439|57|837|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-440|57|838|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-441|57|838|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-442|57|840|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-443|57|840|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-444|57|843|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-445|57|843|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-446|57|845|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-447|57|846|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-448|57|851|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-449|57|851|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-450|57|851|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-451|57|851|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-452|57|851|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-453|57|851|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-454|57|854|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-455|57|854|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-456|57|854|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-457|57|857|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-458|57|858|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-459|57|859|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-460|57|860|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-461|57|860|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-462|57|864|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-463|57|864|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-464|57|866|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-465|57|867|Hyperplastic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-466|57|871|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-467|57|871|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-468|57|873|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-469|57|874|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-470|57|878|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-471|57|879|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-472|57|881|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-473|57|885|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-474|57|887|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-475|57|887|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-476|57|887|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-477|57|889|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-478|57|889|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-479|57|892|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-480|57|894|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-481|57|895|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-482|57|896|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-483|57|899|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-484|57|899|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-485|57|900|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-486|57|906|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-487|57|913|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-488|57|920|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-489|57|920|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-490|57|921|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-491|57|921|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-492|57|921|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-493|57|922|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-494|57|923|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-495|57|929|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-496|57|930|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-497|57|937|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-498|57|937|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-499|57|942|Other deterministic changes|Lower respiratory system|n/a|
2-2-57|Rn-WL150-WLM 25,32-1 -1 0 7/77|1| 77|Rn-222 gas|25|working level months|Inhalation| Inhaled over 6 m at 150 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-57-500|57|942|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-1|58|239|Neoplasia unclassified|Lower respiratory system,MA: 0000032 - thoracic cavity|,MPATH: 238 - hemangioblastoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-2|58|243|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-3|58|289|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-4|58|302|Other deterministic changes|Whole body|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-5|58|335|Other deterministic changes|Whole body|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-6|58|393|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-7|58|447|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-8|58|447|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-9|58|463|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-10|58|474|Other deterministic changes|Whole body|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-11|58|495|Other deterministic changes|Whole body|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-12|58|498|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-13|58|501|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-14|58|501|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-15|58|509|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-16|58|509|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-17|58|530|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-18|58|544|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-19|58|554|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-20|58|560|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-21|58|567|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-22|58|571|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-23|58|574|Neoplasia malignant|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-24|58|579|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| metastatic,MPATH: 409 - fibrous histiocytoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-25|58|581|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-26|58|582|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-27|58|585|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-28|58|588|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-29|58|588|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-30|58|592|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-31|58|599|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-32|58|607|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-33|58|607|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-34|58|610|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-35|58|610|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-36|58|610|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system| benign,MPATH: 551 - sarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-37|58|613|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-38|58|614|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-39|58|615|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-40|58|616|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-41|58|616|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-42|58|620|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-43|58|620|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-44|58|620|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-45|58|623|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-46|58|627|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-47|58|627|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-48|58|630|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-49|58|630|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-50|58|631|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-51|58|631|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver| metastatic,MPATH: 551 - sarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-52|58|634|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-53|58|635|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-54|58|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-55|58|641|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-56|58|641|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-57|58|641|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-58|58|641|Neoplasia benign|Bloodvessels among cardiovascular system| benign|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-59|58|642|Neoplasia malignant|Bloodvessels among cardiovascular system| benign|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-60|58|642|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-61|58|656|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-62|58|656|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-63|58|656|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-64|58|658|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-65|58|658|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-66|58|662|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-67|58|662|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-68|58|663|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-69|58|669|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-70|58|669|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-71|58|673|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-72|58|678|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-73|58|679|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-74|58|683|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-75|58|683|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-76|58|684|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-77|58|684|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-78|58|685|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-79|58|686|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-80|58|686|Neoplasia unclassified|Nervous system and special sense organs,MA: 0000261 - eye| metastatic,MPATH: 218 - neoplasm|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-81|58|687|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-82|58|690|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-83|58|690|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-84|58|691|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-85|58|694|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 551 - sarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-86|58|700|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-87|58|704|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-88|58|708|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-89|58|708|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-90|58|711|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-91|58|711|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-92|58|711|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-93|58|712|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-94|58|712|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-95|58|713|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-96|58|715|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-97|58|718|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-98|58|718|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-99|58|718|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-100|58|720|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-101|58|720|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-102|58|720|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-103|58|722|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| metastatic,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-104|58|722|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-105|58|722|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-106|58|722|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-107|58|722|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-108|58|722|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-109|58|725|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-110|58|725|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-111|58|725|Neoplasia malignant|Lower respiratory system,MA: 0000032 - thoracic cavity|,MPATH: 551 - sarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-112|58|726|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-113|58|727|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-114|58|727|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-115|58|728|Neoplasia malignant|Lymphatic vessels among cardiovascular system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-116|58|728|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-117|58|729|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-118|58|732|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-119|58|732|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-120|58|732|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-121|58|734|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-122|58|734|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-123|58|734|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-124|58|739|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-125|58|739|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 219 - adnexal and skin appendage tumor|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-126|58|739|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-127|58|739|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-128|58|739|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-129|58|739|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-130|58|740|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-131|58|740|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-132|58|740|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-133|58|741|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-134|58|742|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-135|58|743|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-136|58|743|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-137|58|746|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-138|58|746|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-139|58|747|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-140|58|750|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-141|58|0|Other deterministic changes|Whole body|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-142|58|750|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-143|58|750|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-144|58|753|Neoplasia malignant|Other local manifestations and miscellaneus| metastatic|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-145|58|754|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-146|58|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-147|58|755|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-148|58|756|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-149|58|756|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-150|58|756|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-151|58|757|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-152|58|761|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-153|58|761|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-154|58|762|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-155|58|762|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-156|58|763|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-157|58|764|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-158|58|764|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-159|58|764|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-160|58|767|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-161|58|767|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-162|58|768|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-163|58|768|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-164|58|769|Neoplasia malignant|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-165|58|769|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-166|58|769|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-167|58|769|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-168|58|771|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-169|58|771|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-170|58|771|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-171|58|771|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-172|58|774|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-173|58|778|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-174|58|778|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-175|58|782|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-176|58|782|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-177|58|784|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-178|58|784|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-179|58|784|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-180|58|784|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-181|58|788|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-182|58|788|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| metastatic,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-183|58|789|Neoplasia benign|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-184|58|790|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-185|58|790|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-186|58|790|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-187|58|790|Neoplasia benign|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-188|58|791|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-189|58|792|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-190|58|798|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-191|58|798|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-192|58|798|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-193|58|798|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-194|58|798|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-195|58|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-196|58|802|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-197|58|802|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-198|58|803|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-199|58|803|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-200|58|803|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-201|58|805|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-202|58|805|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-203|58|805|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-204|58|806|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-205|58|806|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-206|58|809|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-207|58|809|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-208|58|809|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-209|58|810|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-210|58|811|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-211|58|812|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-212|58|812|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-213|58|812|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-214|58|812|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-215|58|812|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-216|58|813|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-217|58|816|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-218|58|816|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-219|58|816|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-220|58|816|Neoplasia malignant|Other local manifestations and miscellaneus| metastatic|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-221|58|816|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-222|58|817|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas| metastatic,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-223|58|818|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-224|58|818|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-225|58|818|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-226|58|819|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-227|58|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-228|58|823|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-229|58|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-230|58|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-231|58|823|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-232|58|823|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-233|58|824|Neoplasia malignant|Integumentary system,MA: 0000151 - skin| metastatic,MPATH: 446 - squamous cell carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-234|58|825|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-235|58|825|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-236|58|825|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-237|58|826|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-238|58|826|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-239|58|826|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-240|58|826|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-241|58|826|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-242|58|827|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-243|58|827|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-244|58|827|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-245|58|827|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-246|58|830|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-247|58|830|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-248|58|830|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-249|58|830|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-250|58|830|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-251|58|830|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-252|58|830|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-253|58|830|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland| metastatic,MPATH: 218 - neoplasm|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-254|58|831|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-255|58|831|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-256|58|831|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-257|58|832|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-258|58|832|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-259|58|832|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-260|58|832|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-261|58|832|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-262|58|833|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-263|58|833|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-264|58|834|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-265|58|837|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-266|58|837|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-267|58|838|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-268|58|838|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-269|58|838|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-270|58|839|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-271|58|839|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-272|58|840|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-273|58|840|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-274|58|841|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-275|58|841|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-276|58|845|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-277|58|845|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-278|58|845|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-279|58|845|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-280|58|845|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-281|58|846|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-282|58|846|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-283|58|846|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-284|58|847|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-285|58|847|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-286|58|847|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-287|58|848|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-288|58|849|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-289|58|852|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-290|58|853|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-291|58|854|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-292|58|854|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-293|58|855|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-294|58|855|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-295|58|855|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-296|58|856|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-297|58|856|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-298|58|856|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-299|58|859|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-300|58|859|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-301|58|859|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-302|58|860|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-303|58|860|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-304|58|860|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-305|58|861|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-306|58|861|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-307|58|861|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 551 - sarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-308|58|861|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-309|58|862|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-310|58|862|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-311|58|863|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-312|58|863|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-313|58|863|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-314|58|863|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-315|58|863|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-316|58|863|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-317|58|863|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-318|58|866|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-319|58|866|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-320|58|866|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-321|58|866|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-322|58|867|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-323|58|867|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-324|58|867|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-325|58|867|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-326|58|868|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-327|58|868|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-328|58|869|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-329|58|870|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-330|58|870|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-331|58|873|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-332|58|873|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-333|58|874|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-334|58|875|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-335|58|875|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-336|58|876|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-337|58|876|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-338|58|876|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-339|58|877|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-340|58|880|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-341|58|880|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-342|58|880|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-343|58|880|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-344|58|880|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-345|58|881|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-346|58|881|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-347|58|881|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-348|58|882|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-349|58|882|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-350|58|882|Neoplasia malignant|Other local manifestations and miscellaneus| metastatic|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-351|58|882|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-352|58|883|Other deterministic changes|Whole body|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-353|58|883|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-354|58|883|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-355|58|883|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-356|58|883|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-357|58|883|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-358|58|884|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-359|58|884|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-360|58|884|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-361|58|887|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-362|58|887|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-363|58|887|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-364|58|887|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-365|58|887|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-366|58|887|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-367|58|887|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-368|58|887|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-369|58|888|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-370|58|888|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-371|58|888|Neoplasia malignant|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-372|58|889|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-373|58|890|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-374|58|890|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-375|58|890|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-376|58|891|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-377|58|891|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-378|58|894|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-379|58|894|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-380|58|901|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-381|58|901|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-382|58|901|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-383|58|901|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-384|58|901|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-385|58|902|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-386|58|903|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-387|58|903|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-388|58|903|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-389|58|904|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-390|58|904|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-391|58|909|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-392|58|910|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-393|58|910|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-394|58|910|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-395|58|912|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-396|58|916|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-397|58|916|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-398|58|919|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-399|58|919|Neoplasia malignant|Bloodvessels among cardiovascular system| benign|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-400|58|922|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-401|58|922|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-402|58|923|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen| benign,MPATH: 242 - hemangiosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-403|58|923|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-404|58|923|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-405|58|923|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-406|58|924|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-407|58|924|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-408|58|924|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-409|58|924|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-410|58|924|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-411|58|924|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-412|58|924|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-413|58|924|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-414|58|924|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-415|58|924|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-416|58|924|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-417|58|924|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-418|58|924|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-419|58|924|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-420|58|924|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-421|58|924|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-422|58|924|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-423|58|924|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-424|58|925|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-425|58|925|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system| benign,MPATH: 551 - sarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-426|58|925|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-427|58|926|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-428|58|926|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-429|58|929|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-430|58|929|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-431|58|930|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-432|58|930|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-433|58|931|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-434|58|933|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-435|58|936|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-436|58|937|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-437|58|937|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-438|58|937|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-439|58|937|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-440|58|938|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-441|58|938|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-442|58|939|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-443|58|939|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-444|58|939|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-445|58|939|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-446|58|940|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-447|58|940|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-448|58|943|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-449|58|946|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-450|58|946|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-451|58|947|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-452|58|947|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-453|58|947|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-454|58|947|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-455|58|952|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-456|58|952|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-457|58|952|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-458|58|954|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-459|58|954|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-460|58|957|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-461|58|958|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| benign,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-462|58|960|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-463|58|960|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-464|58|960|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-465|58|961|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland| benign,MPATH: 549 - carcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-466|58|961|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-467|58|961|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-468|58|973|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-469|58|973|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-470|58|974|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-471|58|975|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-472|58|975|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-473|58|982|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-474|58|985|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-475|58|988|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-476|58|988|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-477|58|989|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-478|58|989|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-479|58|989|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-480|58|989|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-481|58|992|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-482|58|992|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-483|58|992|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-484|58|993|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-485|58|993|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-486|58|993|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-487|58|993|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-488|58|994|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-489|58|994|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-490|58|995|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-491|58|995|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-492|58|995|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-493|58|995|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-494|58|996|Hyperplastic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-495|58|996|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-496|58|996|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-497|58|996|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-498|58|999|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-499|58|999|Other deterministic changes|Lower respiratory system|n/a|
2-2-58|Rn-WL100-WLM 50,RN3-46 12/80|1| 77|Rn-222 gas|50|working level months|Inhalation| Inhaled over 6 m at 100 WL|500 (500 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|lifespan study comparison dose rate|2-2-58-500|58|999|Other deterministic changes|Lower respiratory system|n/a|
		
